: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Dermatology

Free Subscription

Articles published in Br J Dermatol
Retrieve available abstracts of 626 articles:
HTML format

Single Articles

December 2025

SMITH A, Chow C
Patient-Centred Perspectives - Empowerment, Engagement, and the Future of Cardiovascular Prevention in Psoriasis.
Br J Dermatol. 2025 Dec 13:ljaf513. doi: 10.1093.
PubMed

HAS C
Skin fragility or epidermal differentiation disorder: the devil is in the details.
Br J Dermatol. 2025 Dec 11:ljaf514. doi: 10.1093.
PubMed

PETUKHOVA L, Dand N, Watts K, Saklatvala J, et al
The Skin Genetics Consortium.
Br J Dermatol. 2025 Dec 11:ljaf496. doi: 10.1093.
PubMed

KAHLER S, Yan S, Mothershaw A, Leo F, et al
Automated classification of site-specific cutaneous photodamage using a convolutional neural network and 3D total body photography.
Br J Dermatol. 2025 Dec 10:ljaf516. doi: 10.1093.
PubMed Abstract available

WITKAM WCAM, Mathieu A, Dal Belo SE, Moreau M, et al
Distinct Bacterial Facial Cutaneous Microbiota Compositions in Adolescents with Acne Vulgaris: A Population-Based Cross-Sectional Observational Study.
Br J Dermatol. 2025 Dec 10:ljaf508. doi: 10.1093.
PubMed Abstract available

RAMESSUR R, Loset M
Sleep and psoriasis: an emerging modifiable risk factor?
Br J Dermatol. 2025 Dec 9:ljaf502. doi: 10.1093.
PubMed

ZHAO P, Chew C, Szeto P, Berry W, et al
Genomic copy number burden distinguishes the diagnosis and prognosis of primary dermal melanoma.
Br J Dermatol. 2025 Dec 9:ljaf507. doi: 10.1093.
PubMed Abstract available

ACENCIO ML, Lopata O, Hemedan AA, Dand N, et al
The inflammatory skin disease map: an interactive computational resource focused on psoriasis and atopic dermatitis molecular mechanisms.
Br J Dermatol. 2025 Dec 2:ljaf491. doi: 10.1093.
PubMed

XU X, Li W, Sun K, Hu F, et al
scRNA-seq and Proteomics Uncover Glycolytic Dysregulation Linking Skin and Systemic Inflammation in Dermatomyositis.
Br J Dermatol. 2025 Dec 2:ljaf486. doi: 10.1093.
PubMed Abstract available

VAN ROOIJ N, Sparkes A
Biologic and Small-Molecule Therapies for Chronic Plaque Psoriasis in People Living with HIV: Current Evidence and Clinical Practical Considerations.
Br J Dermatol. 2025 Dec 1:ljaf493. doi: 10.1093.
PubMed

November 2025

WANG D, Wu J, Guo Q, Li Z, et al
Ivarmacitinib ointment for the treatment of adults with mild-to-moderate atopic dermatitis: phase 3 part of a randomized, double-blind, placebo-controlled, phase 2/3 clinical trial.
Br J Dermatol. 2025 Nov 29:ljaf482. doi: 10.1093.
PubMed Abstract available

MILTNER LA, Loman L, Ortiz JA, Zhang J, et al
Multimorbidity and Atopic Dermatitis in a Population-Based Cohort: Severity-Dependent Association With Distinct Non-Atopic Multimorbidity Patterns.
Br J Dermatol. 2025 Nov 27:ljaf475. doi: 10.1093.
PubMed Abstract available

KNOPFEL N, Barberan-Martin S, Polubothu S, Sauvadet A, et al
Gene discovery in extensive dermal melanocytosis reveals multiple mosaic causes.
Br J Dermatol. 2025 Nov 27:ljaf481. doi: 10.1093.
PubMed Abstract available

GOMEZ-TOMAS A, Gonzalez-Cruz C, Garcia-Patos V, Ferrandiz-Pulido C, et al
Immunosuppressive regimens and skin cancer risk in solid-organ transplant recipients.
Br J Dermatol. 2025 Nov 27:ljaf483. doi: 10.1093.
PubMed Abstract available

MARJANOVIC M, Mikiver R, Nielsen K, Isaksson K, et al
Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma: A Nationwide Population-Based Registry Study from Sweden.
Br J Dermatol. 2025 Nov 26:ljaf478. doi: 10.1093.
PubMed Abstract available

FERTITTA L, Sarin KY, Romo CG, Bergqvist C, et al
Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: Development, validation and severity strata of the cNF-PUSH-D.
Br J Dermatol. 2025 Nov 26:ljaf479. doi: 10.1093.
PubMed Abstract available

STERN R
Cancer and Psoriasis: Known Risk factors explain the Association.
Br J Dermatol. 2025 Nov 25:ljaf477. doi: 10.1093.
PubMed

CHENG AY, Lin CC, Cheng AT, Chou MP, et al
Incidence of skin cancer versus overall de novo malignancies among living donor liver transplant recipients in Taiwan: a cohort study.
Br J Dermatol. 2025 Nov 24:ljaf472. doi: 10.1093.
PubMed

XIANG Z, Chen G, Yin L, Xi X, et al
Cutaneous toxicity and management in CEA-targeted Chimeric Antigen Receptor T-cell therapy for solid tumors.
Br J Dermatol. 2025 Nov 24:ljaf473. doi: 10.1093.
PubMed

ZHAO M, Xu Z, Wu L, Wei Z, et al
Safety and efficacy of stapokibart, an anti-IL-4Ralpha monoclonal antibody, in children aged 6-11 years with moderate-to-severe atopic dermatitis: An open-label, single-arm phase 1b/2a trial.
Br J Dermatol. 2025 Nov 24:ljaf455. doi: 10.1093.
PubMed Abstract available

CHEN J, Francis P, Martinez A, Marre E, et al
Exploring sexual health in patients with cutaneous T-cell lymphoma: a mixed methods study.
Br J Dermatol. 2025 Nov 20:ljaf466. doi: 10.1093.
PubMed

FRANZ A, Constantinou A, Hillmann K, Chasapi V, et al
Quality of life, psychosocial difficulties and bullying in paediatric patients with alopecia areata: a European cross-sectional study.
Br J Dermatol. 2025;193:1165-1173.
PubMed Abstract available

INGRAM JR, Wozniak MB, Passera A, Uhlmann L, et al
The Hidradenitis Suppurativa Symptom and Impact Diary: Development and psychometric evaluation of a novel set of patient-reported outcomes for hidradenitis suppurativa.
Br J Dermatol. 2025;193:1155-1164.
PubMed Abstract available

MEHTA H, Bishnoi A, Vinay K, Kumaran MS, et al
Comparative efficacy of topical tofacitinib versus topical tacrolimus in the treatment of localized vitiligo: a randomized investigator-blinded intraindividual trial.
Br J Dermatol. 2025;193:1112-1119.
PubMed Abstract available

ZHANG H, Paus R, Dai Y, Song X, et al
Transient receptor potential channels in hair follicle biology: physiological significance and translational relevance.
Br J Dermatol. 2025;193:1065-1074.
PubMed Abstract available

AKAIKE T, Ch'en PY, Hippe DS, Gilmour MW, et al
Merkel cell carcinoma in solid organ transplant recipients: prognosis and response to immunotherapy.
Br J Dermatol. 2025;193:1221-1231.
PubMed Abstract available

KINSLER VA
Mosaic disorders affecting pigmentation - part 2: how to make a genetic diagnosis.
Br J Dermatol. 2025;193:1047-1055.
PubMed Abstract available

KUMAR S, Ralser DJ, Wenzel J, Frank J, et al
Beneath the surface: delineating the subtypes of Dowling-Degos disease.
Br J Dermatol. 2025;193:1075-1089.
PubMed Abstract available

BOUDHABHAY I, Bellon N, Avramescu M, Bataille P, et al
Prevalence of kidney complications in a large cohort of patients with recessive dystrophic epidermolysis bullosa.
Br J Dermatol. 2025;193:1204-1213.
PubMed Abstract available

CHEN HW, Barber G, Foster J, Zigler CK, et al
Validation of CXCL9 as a biomarker of morphoea disease state and severity through longitudinal analysis.
Br J Dermatol. 2025;193:1174-1181.
PubMed Abstract available

SCHMITT T, Haneberg J, Egu D, Sebastia Moron C, et al
The role of PKC subtype-specific signaling in the regulation of adhesion in human keratinocytes and skin in pemphigus.
Br J Dermatol. 2025 Nov 15:ljaf458. doi: 10.1093.
PubMed Abstract available

MALEKAN M, Rahmatpour Rokni G, Gholizadeh N, Mollapour Sisakht M, et al
Efficacy and Safety of Baricitinib Versus Azathioprine Combined with Topical Corticosteroids in Patients with Moderate-to-Severe Atopic Dermatitis: A Single-Center, Randomized, Open-Label Trial.
Br J Dermatol. 2025 Nov 14:ljaf456. doi: 10.1093.
PubMed Abstract available

VAN HOUT NE, Nevot G, Jansen PAM, Mannan AA, et al
From prebiotics to engineered microbes: microbe-inspired therapies for atopic dermatitis.
Br J Dermatol. 2025 Nov 13:ljaf451. doi: 10.1093.
PubMed Abstract available

DYANKOVA-PEEVA D, Kinsler VA
Complete spontaneous resolution of NRAS-mosaic multiple congenital melanocytic naevi - proof of principle for therapeutic mole reversal.
Br J Dermatol. 2025 Nov 11:ljaf447. doi: 10.1093.
PubMed

LISLE TL, Weis-Banke SE, Ahmad SM, Holmstrom MO, et al
Harnessing Arginase-2-specific CD8+ T cells to target immunosuppressive Cutaneous T cell Lymphoma.
Br J Dermatol. 2025 Nov 10:ljaf450. doi: 10.1093.
PubMed Abstract available

LOFT N, Zachariae C, Kaur-Knudsen D, Bunick CG, et al
Pustular psoriasis following treatment with biologics among patients with plaque psoriasis: a nationwide cohort study.
Br J Dermatol. 2025 Nov 8:ljaf448. doi: 10.1093.
PubMed

STAVE SDW, Nymand LK, Ferrucci SM, Ribero S, et al
Patient preferences for treatment of atopic dermatitis: findings from the Danish Skin Cohort.
Br J Dermatol. 2025 Nov 7:ljaf388. doi: 10.1093.
PubMed

SIEBORG J, Zwahlen D, Maul JT, Haedersdal M, et al
Psychological distress and unmet supportive care needs in melanoma-survivors and high-risk patients for melanoma: A Swiss cross-sectional study.
Br J Dermatol. 2025 Nov 5:ljaf439. doi: 10.1093.
PubMed Abstract available

FOURMOUND S, Dumonteil S, Akil H, Couraud A, et al
Specific serum and skin immunological profiles of patients with bullous pemphigoid requiring biologic therapies.
Br J Dermatol. 2025 Nov 4:ljaf430. doi: 10.1093.
PubMed

TSAKOK T, Yiu ZZN, Smith CH
Psoriasis at high-impact sites: shifting the paradigm.
Br J Dermatol. 2025 Nov 4:ljaf404. doi: 10.1093.
PubMed

MI Z, Yu Y, Wang Z, Bai F, et al
Excessive Glycine Loop Variations in the Keratin 10 Tail Domain and Implications for Skin Fragility.
Br J Dermatol. 2025 Nov 4:ljaf436. doi: 10.1093.
PubMed Abstract available

AGATHANGELIDI TA, Carson L, Doolan BJ, Dubois A, et al
An ontological analysis of a dataset of curated dermatological gene disease associations (G2P-Skin).
Br J Dermatol. 2025 Nov 3:ljaf438. doi: 10.1093.
PubMed

KAHLER S, Primiero C, Mothershaw A, Jayasinghe D, et al
3D-total body photography identifies cutaneous phenotypes associated with late-onset invasive melanoma risk.
Br J Dermatol. 2025 Nov 3:ljaf440. doi: 10.1093.
PubMed Abstract available

LIU Y, Tan L
A Missing Piece in the Cutaneous Melanoma Puzzle: Metabolic Reprogramming Driven by Loss of TET2/5hmC.
Br J Dermatol. 2025 Nov 3:ljaf442. doi: 10.1093.
PubMed

JAMES ML, Freeman A, Haider A, Kravvas G, et al
Perianal melanosis, benign genital melanosis and lichen sclerosus.
Br J Dermatol. 2025 Nov 3:ljaf443. doi: 10.1093.
PubMed

BRUGRAND O, O'Shea S
From Flare to Freedom: A Young Woman's Guttate Psoriasis Journey.
Br J Dermatol. 2025 Nov 1:ljaf433. doi: 10.1093.
PubMed

October 2025

THIMJO J, Das D, Enerback C, Ludvigsson J, et al
Infections during childhood as predisposing factors to develop Psoriasis Vulgaris into early adulthood.
Br J Dermatol. 2025 Oct 31:ljaf416. doi: 10.1093.
PubMed Abstract available

MCPHERSON T, Ravenscroft JC, Fazel M, Nancarrow R, et al
Reframing 'Dermatitis Artefacta' in Children and Young People as a Functional Skin Disorder: building trust, improving communication and enhancing recovery.
Br J Dermatol. 2025 Oct 29:ljaf426. doi: 10.1093.
PubMed

LEE KJ, Kao YC, Jiang A, Prokofyeva A, et al
Subclinical Fields of BRAF V600E-Mutant Melanocytes Populate Human Skin and Are Enriched Around Melanoma and Naevi.
Br J Dermatol. 2025 Oct 28:ljaf412. doi: 10.1093.
PubMed Abstract available

YOSHINO K, Fujisawa Y, Yoshikawa S, Maekawa T, et al
Nivolumab in the treatment of non-melanoma skin cancer: multi-center, retrospective analysis of 46 cases.
Br J Dermatol. 2025 Oct 27:ljaf420. doi: 10.1093.
PubMed

SINGH J, Korevaar JC, van Houten KM, Vondenhoff MFR, et al
Exploring patients' views on a more proactive role for allied healthcare professionals in the identification of suspicious skin lesions: a qualitative study.
Br J Dermatol. 2025 Oct 27:ljaf421. doi: 10.1093.
PubMed

IVERT LU, Anveden-Berglind I, Gembert K, Eriksson J, et al
The Risk of Venous Thromboembolism in Atopic Dermatitis: A Population-Based Cohort Study.
Br J Dermatol. 2025 Oct 24:ljaf418. doi: 10.1093.
PubMed Abstract available

ZHAO S, Xie J, He Y, Li L, et al
Unveiling the TBX2-driven molecular landscape of large/giant congenital melanocytic nevi: from single-cell sequencing to targeted therapy.
Br J Dermatol. 2025 Oct 23:ljaf415. doi: 10.1093.
PubMed

GRAIER T, Lwin SM, Griffiths CEM
Breaking the Cycle of Psoriasis: The Role for Early Intervention.
Br J Dermatol. 2025 Oct 22:ljaf403. doi: 10.1093.
PubMed

MISTRY K, Bagdatoglou G, Daniels S, Lorigan P, et al
The economic burden of melanoma in the UK: A stage-specific cost analysis underscoring the importance of prevention and early diagnosis.
Br J Dermatol. 2025 Oct 22:ljaf393. doi: 10.1093.
PubMed

LIANG B, Pu M, Xu YN, Li Y, et al
Dandruff scalp microbiome exhibits flake severity and sex-related differences.
Br J Dermatol. 2025;193.
PubMed Abstract available

XU YN, Salgaonkar N, Pu M, Hawkins S, et al
Unveiling acne microbiome signatures: the role of the microbiome and the impact of a facewash formula containing plant-derived monoterpenes.
Br J Dermatol. 2025;193.
PubMed Abstract available

YUE X, Wang H, Xu YN, Chu CC, et al
Microbiome network: a robust biomarker of skin health.
Br J Dermatol. 2025;193.
PubMed Abstract available

CHEVITI B, Cawley A, Malviya S, Murphy B, et al
Mild skin cleansers strengthen microbiome networks without affecting the skin microbiome.
Br J Dermatol. 2025;193.
PubMed Abstract available

ARIAS-MERINO G, Benito-Lozano J, Gomez-Martinez M, Villaverde-Hueso A, et al
Health-related quality-of-life evaluation in epidermolysis bullosa: a scoping review.
Br J Dermatol. 2025;193:856-864.
PubMed Abstract available

ITO S, Kolbe L, Weets G, Rogers T, et al
Exogenous ochronosis by hydroquinone is not caused by inhibition of homogentisate dioxygenase but potentially by tyrosinase-catalysed metabolism of hydroquinone.
Br J Dermatol. 2025;193:959-967.
PubMed Abstract available

BROADAWAY KA, Sun Q, Edmiston SN, Currin KW, et al
Genomic loci and molecular genetic mechanisms for hidradenitis suppurativa.
Br J Dermatol. 2025;193:948-958.
PubMed Abstract available

KINSLER VA, Knopfel N, Polubothu S
Segmental macular hyperpigmentation: new genes, new clinical implications.
Br J Dermatol. 2025;193:987-995.
PubMed Abstract available

KINSLER VA
Mosaic disorders affecting pigmentation - part 1: how to make a clinical diagnosis.
Br J Dermatol. 2025;193:819-829.
PubMed Abstract available

SWIDERSKI M, Lewis S, Vinogradova Y, Ridd MJ, et al
Incidence rates of bullous pemphigoid, herpes zoster and urticaria following the start of the COVID-19 vaccination programme in the UK: a population-based cohort study.
Br J Dermatol. 2025;193:889-897.
PubMed Abstract available

ZHU G, Gordon S, Green AC, Martin NG, et al
Halving of Australian children's naevus counts during 1992-2016 and change in sun behaviour.
Br J Dermatol. 2025;193:898-906.
PubMed Abstract available

SZONDI DC, Crompton RA, Oon L, Subramaniam N, et al
Keratinocyte arginase 1 regulates proinflammatory responses and drives re-epithelialization via lipocalin 2.
Br J Dermatol. 2025;193:924-935.
PubMed Abstract available

DASKALOPOULOU A, Assrawi E, Diab F, Louvrier C, et al
Low-level NLRP3 mosaicism in chronic urticarial lesions: extending the phenotypic spectrum of NLRP3-related disorders and therapeutic implications.
Br J Dermatol. 2025;193:914-923.
PubMed Abstract available

SILVERBERG JI, Skayem C, Le Floc'h C, Begolka WS, et al
Nearly Half of American Children with Atopic Dermatitis Experience Significant Quality of Life Impairment, Often Underestimated by Parents.
Br J Dermatol. 2025 Oct 17:ljaf411. doi: 10.1093.
PubMed

TAI MC, Wang JY, Yang CC, Tsai SJ, et al
Zinc deficiency in bullous pemphigoid: predisposing factors, skin fragility, and renal function impact.
Br J Dermatol. 2025 Oct 16:ljaf408. doi: 10.1093.
PubMed

MCGRATH JA
From connective tissue builders to cellular architects: the journey of the skin fibroblast.
Br J Dermatol. 2025 Oct 16:ljaf407. doi: 10.1093.
PubMed

PARK JJ, Nguyen CV, Choi JN, Guitart J, et al
Chimeric antigen receptor T-cell therapy-related T-cell malignancies: raising awareness of cutaneous manifestations.
Br J Dermatol. 2025 Oct 15:ljaf297. doi: 10.1093.
PubMed

LAI P, Cao M, Li M, Jiang Y, et al
Atopic dermatitis shares a distinct T helper 2 subset with mycosis fungoides that exhibits autonomous proliferative potential.
Br J Dermatol. 2025 Oct 14:ljaf362. doi: 10.1093.
PubMed

LEBWOHL MG, Blauvelt A, Bagel J, Gogineni R, et al
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis over five years in patients living with obesity.
Br J Dermatol. 2025 Oct 14:ljaf392. doi: 10.1093.
PubMed

MELCHIONDA V, van Bodegraven B, Archer CMG, Perkins W, et al
National epidemiology of dermatofibromasarcoma protuberans, England 2013-2022.
Br J Dermatol. 2025 Oct 14:ljaf401. doi: 10.1093.
PubMed

AKINSHEMOYIN VAUGHN OL
The Long Road to Standardization in Vulvar Lichen Sclerosus Research.
Br J Dermatol. 2025 Oct 13:ljaf405. doi: 10.1093.
PubMed

TRAFFORD AM, Schonmann Y, Chen TC, Egeberg A, et al
Psoriasis and the risk of 26 cancers: pooled population-based cohort studies from Denmark, England, Israel, and Taiwan.
Br J Dermatol. 2025 Oct 12:ljaf399. doi: 10.1093.
PubMed Abstract available

LIPNICK MS, Chen D, Law T, Moore K Jr, et al
Comparison of methods for characterizing skin pigment diversity in research cohorts.
Br J Dermatol. 2025 Oct 10:ljaf397. doi: 10.1093.
PubMed Abstract available

HO G, Smith AL, Collgros H, Sinz C, et al
Clinician and patient perspectives on implementation of a remote interpretation model of reflectance confocal microscopy for skin cancer diagnosis: a qualitative study using an acceptability framework.
Br J Dermatol. 2025 Oct 9:ljaf348. doi: 10.1093.
PubMed

WEHKAMP U, Assaf C
Primary cutaneous CD4(+) small/medium T-cell lymphoproliferative disorder - a truly "benign" disease?
Br J Dermatol. 2025 Oct 5:ljaf389. doi: 10.1093.
PubMed

WRIGHT AK, Swan R, Xu J, Lwin SM, et al
Skin disease in the Eastern Cape (SKINSCAPE): a Global Psoriasis Atlas point prevalence study in rural South Africa.
Br J Dermatol. 2025 Oct 3:ljaf386. doi: 10.1093.
PubMed Abstract available

SVEDBOM A
Potential additional benefits of glucagon-like peptide-1 receptor agonists in psoriasis.
Br J Dermatol. 2025 Oct 1:ljaf382. doi: 10.1093.
PubMed

September 2025

KEDDIE SH, Griffiths CEM, Jemec GBE, Ezzedine K, et al
Grand Challenges for Skin Health Revisited: The International League of Dermatological Societies (ILDS) Skin Disease Atlases.
Br J Dermatol. 2025 Sep 30:ljaf358. doi: 10.1093.
PubMed

FISCHER GM, Fang R, Xu S, Karkempetzaki AI, et al
Loss of TET2 Facilitates Aggressive Behavior in Cutaneous Melanoma by Inducing PGC1alpha/Oxidative Phosphorylation (OXPHOS).
Br J Dermatol. 2025 Sep 27:ljaf378. doi: 10.1093.
PubMed Abstract available

AFTAB Y, Moloney S, Ho B, Raymond B, et al
Four decades of stagnation: A qualitative exploration of the lived experience of Atopic Dermatitis across ethnically and sexually diverse adults in the United Kingdom.
Br J Dermatol. 2025 Sep 26:ljaf377. doi: 10.1093.
PubMed

DRUCKER AM, Williams E, Kaffenberger B, Dodiuk-Gad RP, et al
Long-term morbidity and quality of life among survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
Br J Dermatol. 2025 Sep 26:ljaf380. doi: 10.1093.
PubMed

WANG SP, Myers E, Arents BWM, Flohr C, et al
Caution regarding interpretation of trends for the global burden of atopic dermatitis and asthma.
Br J Dermatol. 2025 Sep 26:ljaf369. doi: 10.1093.
PubMed

YIU ZZN
Previous ineligibility for or treatment failure of ciclosporin does not influence lebrikizumab efficacy in atopic dermatitis.
Br J Dermatol. 2025 Sep 23:ljaf316. doi: 10.1093.
PubMed

WARREN RB, de Bruin-Weller M, Tsianakas A, Khemis A, et al
Efficacy and safety of lebrikizumab in adult and adolescent patients with moderate-to-severe atopic dermatitis inadequately controlled with or ineligible for ciclosporin A: a placebo-controlled, randomized phase IIIb clinical study (ADvantage).
Br J Dermatol. 2025 Sep 22:ljaf285. doi: 10.1093.
PubMed Abstract available

FOSTER EL, Davis MI, Li AX, Kottner J, et al
Identification of key symptoms for a core outcome set for research in vulvar lichen sclerosus: a CORALS symptom domain initiative.
Br J Dermatol. 2025 Sep 22:ljaf374. doi: 10.1093.
PubMed Abstract available

TAN W, Chen Z, Xu M, Chen J, et al
Single-cell RNA sequencing reveals transcriptomic landscape and potential targets for large/giant congenital melanocytic nevi.
Br J Dermatol. 2025 Sep 20:ljaf360. doi: 10.1093.
PubMed Abstract available

MAI JZ, Kitahara CM, Sargen MR, Little MP, et al
Residential ambient ultraviolet B and ultraviolet A and incidence of keratinocyte carcinoma in the nationwide US Radiologic Technologists cohort.
Br J Dermatol. 2025;193:678-686.
PubMed Abstract available

HODAK E, Amitay-Laish I, Bagot M, Battistella M, et al
ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part two: treatment.
Br J Dermatol. 2025;193:653-661.
PubMed Abstract available

JOPP H, Kraft A, Hoffmann B, Merkel R, et al
Preclinical validation of PKC412 as a therapy candidate for epidermolysis bullosa simplex across multiple keratin pathogenic variants.
Br J Dermatol. 2025;193:741-757.
PubMed Abstract available

AKIYAMA M, Choate K, Hernandez-Martin A, Aldwin-Easton M, et al
Nonsyndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy.
Br J Dermatol. 2025;193:619-641.
PubMed Abstract available

PALLER AS, Teng J, Mazereeuw-Hautier J, Hernandez-Martin A, et al
Syndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy.
Br J Dermatol. 2025;193:592-618.
PubMed Abstract available

ZHANG L, Wang M, Zhang L, Liang Y, et al
Efficacy and Safety of Pumecitinib Gel for Treating Mild-to-moderate Atopic Dermatitis: a Multicentre, Randomised, Double-blind, Parallel, Placebo-controlled Phase IIb Clinical Trial.
Br J Dermatol. 2025 Sep 18:ljaf363. doi: 10.1093.
PubMed Abstract available

FOSTER J, Sarlashkar P, Lu G, Teske N, et al
Disparities in online patient education materials for rheumatic skin diseases.
Br J Dermatol. 2025 Sep 15:ljaf371. doi: 10.1093.
PubMed

WHITEMAN DC
BRAF testing for melanoma in England.
Br J Dermatol. 2025 Sep 12:ljaf373. doi: 10.1093.
PubMed

HE H, Xiao M, Song L, Tian Y, et al
Lipidome-microbiome crosstalk as an outer niche in the skin: regulatory networks in health and disease.
Br J Dermatol. 2025 Sep 11:ljaf353. doi: 10.1093.
PubMed Abstract available

AHMED S, van Bodegraven B, Proby C, Harwood CA, et al
Ethnicity and the epidemiology of skin cancer incidence: a national retrospective population-based study in England, 2013-20.
Br J Dermatol. 2025 Sep 10:ljaf352. doi: 10.1093.
PubMed Abstract available

SAMOTIJ D, Reich A
Could TYK2 inhibition be a breakthrough in the effective treatment of cutaneous lupus erythematosus?
Br J Dermatol. 2025 Sep 9:ljaf357. doi: 10.1093.
PubMed

BASHALL SEL, Thomas BR, Sim V, Wain M, et al
Primary Cutaneous CD4+ Small Medium T Cell Lymphoproliferative Disorder - 20 years of experience from a specialist centre.
Br J Dermatol. 2025 Sep 8:ljaf338. doi: 10.1093.
PubMed Abstract available

BOULANGER KP, McCuaig C, Roy AA, Kokta V, et al
Striking improvement with targeted therapy in an ALK-positive atypical giant congenital melanocytic naevus of the right lower limb: a case report.
Br J Dermatol. 2025 Sep 8:ljaf334. doi: 10.1093.
PubMed

WANG Y, Xin X, Xu Z
Primary Annular Psoriasis.
Br J Dermatol. 2025 Sep 5:ljaf340. doi: 10.1093.
PubMed

GHOSH S, Pavlova O, Latshaw A, Kim D, et al
Multi-Harmonic Imaging-Based Automated Recognition of Cutaneous T-Cell Lymphoma.
Br J Dermatol. 2025 Sep 4:ljaf345. doi: 10.1093.
PubMed Abstract available

HAFERKAMP S, Schilling B, Berking C, Drexler K, et al
Breaking primary checkpoint inhibitor resistance with intermittent alkylating chemotherapy in patients with metastatic melanoma - Results of a multicenter phase II study.
Br J Dermatol. 2025 Sep 4:ljaf350. doi: 10.1093.
PubMed Abstract available

MISTRY K, Jeffrey P, Levell NJ, Kennedy O, et al
A national cohort study of melanoma BRAF status, testing patterns, patient and tumour characteristics, treatment and survival in England 2016-21.
Br J Dermatol. 2025 Sep 3:ljaf351. doi: 10.1093.
PubMed Abstract available

LIU Z, Zheng DQ, Fan YM
Recurrent eczematous dermatitis in a port-wine stain: Meyerson phenomenon.
Br J Dermatol. 2025 Sep 3:ljaf342. doi: 10.1093.
PubMed

OLBRICH H, Kridin K, Zirpel H, Hernandez G, et al
GLP-1RA and reduced mortality, cardiovascular and psychiatric risks in psoriasis: a large-scale cohort study.
Br J Dermatol. 2025 Sep 3:ljaf346. doi: 10.1093.
PubMed Abstract available

TENG YS, Wang HJ
Kaposi varicelliform eruption.
Br J Dermatol. 2025 Sep 2:ljaf343. doi: 10.1093.
PubMed

ZHANG J, Silverberg JI, Guo J, Yun J, et al
Rademikibart monotherapy for moderate-to-severe atopic dermatitis in a 1-year, randomized, phase II trial (SEASIDE CHINA): initial two-week dosing, followed by two-week or four-week dosing.
Br J Dermatol. 2025 Sep 2:ljaf347. doi: 10.1093.
PubMed Abstract available

August 2025

GU Y, Zhang B
Stink bug-induced cutaneous chromatosis.
Br J Dermatol. 2025 Aug 29:ljaf336. doi: 10.1093.
PubMed

REICH K, Langley RG, Salvador JFS, Staumont-Salle D, et al
Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of 8 clinical trials.
Br J Dermatol. 2025 Aug 29:ljaf309. doi: 10.1093.
PubMed Abstract available

STEIN GOLD L, Gottlieb AB, Armstrong AW, Alkousakis T, et al
SPECTREM Phase 3b Clinical Trial Results Through Week 16: Guselkumab Efficacy and Safety for the Treatment of Low Body Surface Area, Moderate Psoriasis With High-Impact Site Involvement.
Br J Dermatol. 2025 Aug 28:ljaf327. doi: 10.1093.
PubMed Abstract available

XU YN, Pu M, Raut J, Du Y, et al
Skin microbiome as a signature of premature ageing appearance: Manipulation through by use of topical products.
Br J Dermatol. 2025 Aug 27:ljaf098. doi: 10.1093.
PubMed Abstract available

MAUBEC E
Avelumab plus cetuximab in advanced cutaneous squamous cell carcinoma: a strategy to overcome resistance to PD-1 blockade.
Br J Dermatol. 2025 Aug 21:ljaf331. doi: 10.1093.
PubMed

MOSS C
Dermatitis artefacta explains haematohidrosis.
Br J Dermatol. 2025 Aug 21:ljaf329. doi: 10.1093.
PubMed

MATSUDA KM, Harada T, Doi M, Io T, et al
An open-label randomized parallel-group phase I study of the oral Bruton tyrosine kinase inhibitor tirabrutinib in systemic sclerosis.
Br J Dermatol. 2025;193:434-441.
PubMed Abstract available

CHUNG HY, Chen CB, Lee HE, Lu CW, et al
Janus kinase/signal transducer and activator of transcription signalling pathway is involved in the immune mechanism of bullous pemphigoid.
Br J Dermatol. 2025;193:521-531.
PubMed Abstract available

HODAK E, Amitay-Laish I, Bagot M, Battistella M, et al
ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part one: diagnosis and staging.
Br J Dermatol. 2025;193:405-414.
PubMed Abstract available

EL HACHEM M, Caldaro T, Lara-Corrales I, Pope E, et al
Management of oesophageal strictures in inherited epidermolysis bullosa: a clinical practice guideline.
Br J Dermatol. 2025;193:394-404.
PubMed Abstract available

CHRISTOU E, Lalagianni N, McSweeney SM, Cotter C, et al
Psychosocial burden and the impact of illness perceptions and stigma on quality of life, anxiety and depression in alopecia areata: results from the Alopecia + Me study.
Br J Dermatol. 2025;193:458-467.
PubMed Abstract available

MALOVITSKI K, Feller Y, Giladi M, Janagond AB, et al
Loss-of-function variants in DUSP1 encoding dual specificity phosphatase 1 cause palmoplantar keratoderma.
Br J Dermatol. 2025;193:532-543.
PubMed Abstract available

FUCHS M, Mochel M, Radeva MY, Schmitt T, et al
Direct inhibition precedes p38 mitogen activated protein kinase-mediated uncoupling in desmosomes to reduce desmoglein 3 adhesion by pemphigus autoantibodies.
Br J Dermatol. 2025;193:468-479.
PubMed Abstract available

QIAN Q, Gu Y, Luo J, Wu S, et al
Genetic and environmental factors affecting hair density in East Asian populations.
Br J Dermatol. 2025;193:502-513.
PubMed Abstract available

BONE M, Schreyer D, Treanor-Taylor M, Proby CM, et al
The landscape of long noncoding RNA during cutaneous squamous cell carcinoma progression.
Br J Dermatol. 2025;193:490-501.
PubMed Abstract available

SPRECHER E, Ishida-Yamamoto A, Schwartz J, Akiyama M, et al
Palmoplantar epidermal differentiation disorders: a new classification toward pathogenesis-based therapy.
Br J Dermatol. 2025;193:364-380.
PubMed Abstract available

BABER C, Busch L, Klein AL, Infante VHP, et al
Mechanistic in vivo studies of secondary skin-to-skin peanut allergen transfer to determine the impact of hand washing in reducing the risk of cutaneous sensitization.
Br J Dermatol. 2025 Aug 16:ljaf214. doi: 10.1093.
PubMed Abstract available

SHIMOMURA Y
Unravelling the molecular basis for premature diffuse familial sebaceous hyperplasia.
Br J Dermatol. 2025 Aug 12:ljaf320. doi: 10.1093.
PubMed

WASSERER S, Seiringer P, Kurzen N, Jargosch M, et al
TYK2 inhibition improves clinical and molecular hallmarks in various subtypes of cutaneous lupus.
Br J Dermatol. 2025 Aug 8:ljaf293. doi: 10.1093.
PubMed Abstract available

WILLEMZE R, Assaf C, Bagot M, Beylot-Barry M, et al
EORTC/USCLC/ISCL consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders.
Br J Dermatol. 2025 Aug 6:ljaf312. doi: 10.1093.
PubMed Abstract available

July 2025

PALLER AS, Fiorillo L, Becker E, Armesto S, et al
Efficacy and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis: 52-week results from the SPROUT randomized controlled trial.
Br J Dermatol. 2025 Jul 30:ljaf305. doi: 10.1093.
PubMed Abstract available

KELLY ASV, Moustaqim-Barrette A, Xie C, Shah A, et al
Under the arctic sun: assessment of skin cancer risk and sun protection behaviors in Indigenous communities in Nunavik, an emerging at-risk population for skin cancers.
Br J Dermatol. 2025 Jul 30:ljaf290. doi: 10.1093.
PubMed

BECKER JC, Gesierich AH, Leiter U, Zimmer L, et al
Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma - clinical activity and safety results from AliCe, a single-arm, multicentre phase 2 DeCOG trial.
Br J Dermatol. 2025 Jul 26:ljaf303. doi: 10.1093.
PubMed Abstract available

LIANG L, Wang S, Huang S, Sun Y, et al
A gain-of-function variant in NNT causes premature diffuse familial sebaceous hyperplasia.
Br J Dermatol. 2025 Jul 25:ljaf294. doi: 10.1093.
PubMed Abstract available

FOLKMANN CL, Pinborg EH, Iversen M, Ronnstad ATM, et al
The association between hidradenitis suppurativa and psychiatric disease: a systematic review and meta-analysis.
Br J Dermatol. 2025;193:212-220.
PubMed Abstract available

HIEL MAJ, Korte EWH, Tedbirt B, Bolling MC, et al
Outcome measurement in pemphigus clinical research: a scoping review on heterogeneity in outcome reporting and definitions.
Br J Dermatol. 2025;193:221-231.
PubMed Abstract available

TORRELO A, Colmenero I, Alvarez-Twose I
Childhood mastocytosis: challenges and potential shortfalls in current disease classification.
Br J Dermatol. 2025;193:203-211.
PubMed Abstract available

HUANG Z, Zhao W, Xu C, Zheng J, et al
Interleukin (IL)-34 promotes the inflammatory role of IL-1beta-producing myeloid cells in pemphigus lesions.
Br J Dermatol. 2025;193:287-297.
PubMed Abstract available

NOCK MR, Griffiths D, Shields A, Michael K, et al
Measurement properties of the Comprehensive Quality-of-Life Measure for Acne (CompAQ): a cohort study at three international sites.
Br J Dermatol. 2025;193:267-275.
PubMed Abstract available

MOSTAGHIMI A, Craiglow B, King B, Shapiro J, et al
Understanding eyebrow and eyelash involvement in patients with alopecia areata and responsiveness to treatment with baricitinib.
Br J Dermatol. 2025;193:240-249.
PubMed Abstract available

PARAGH G, Huss WJ
Shedding new light on narrowband ultraviolet B phototherapy: balancing psoriasis treatment and carcinogenic risk.
Br J Dermatol. 2025 Jul 16:ljaf218. doi: 10.1093.
PubMed

KWATRA SG, Pereira MP, Misery L, Mollanazar NK, et al
Prurigo nodularis: disease burden, clinical features and approach to management.
Br J Dermatol. 2025 Jul 16:ljaf213. doi: 10.1093.
PubMed Abstract available

CREAMER D
Quality of life assessment in Stevens-Johnson syndrome / toxic epidermal necrolysis (SJS/TEN): damage assessment guides damage limitation.
Br J Dermatol. 2025 Jul 15:ljaf278. doi: 10.1093.
PubMed

GALILI E, Barzilai A, Lev A, Amit S, et al
Genetic, immunological and clinical assessment of isolated chronic recalcitrant dermatophytosis: A prospective study.
Br J Dermatol. 2025 Jul 15:ljaf269. doi: 10.1093.
PubMed Abstract available

LIU D, Hu BD, Mishra A, Patel D, et al
Tape Strips in Inflammatory Skin Disease: A Noninvasive Method for Molecular Insights and Personalized Care.
Br J Dermatol. 2025 Jul 14:ljaf275. doi: 10.1093.
PubMed Abstract available

NARDIN C, Cavalieri C, Lebbe C, Gerard E, et al
Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL).
Br J Dermatol. 2025 Jul 14:ljaf268. doi: 10.1093.
PubMed Abstract available

EPSTEIN Z, Epstein L, Rork J, Koo J, et al
Skin Picking in Down syndrome: A Patient Speaks Out.
Br J Dermatol. 2025 Jul 7:ljaf264. doi: 10.1093.
PubMed

KARPONIS D, Mistry K, Stratigos G, Levell NJ, et al
Can the effects of the COVID-19 pandemic provide insights into the impact of melanoma under-diagnosis and delayed care?
Br J Dermatol. 2025 Jul 3:ljaf263. doi: 10.1093.
PubMed

PAPADAVID E, Scarisbrick J
The critical role of National Referral Centers of excellence in the accurate diagnosis and management of Cutaneous Lymphomas.
Br J Dermatol. 2025 Jul 3:ljaf256. doi: 10.1093.
PubMed

June 2025

AFACH S, Sbidian E
Hormonal therapy and psoriasis risk: a new concern for women's health?
Br J Dermatol. 2025 Jun 30:ljaf261. doi: 10.1093.
PubMed

KRISTYANTO H, Rey Torre S, Cunney A, Dunder K, et al
The European Medicines Agency evaluation of nemolizumab (Nemluvio) for the treatment of moderate-to-severe atopic dermatitis and prurigo nodularis.
Br J Dermatol. 2025 Jun 28:ljaf259. doi: 10.1093.
PubMed

DOUSSET L, Khalife F, Chalopin-Fillot D, Dartigues B, et al
Metabolism-based scoring of cutaneous squamous cell carcinoma to predict tumor features and responses to treatment by DHODH inhibitors.
Br J Dermatol. 2025 Jun 27:ljaf253. doi: 10.1093.
PubMed Abstract available

CAI ZR, Kim J, Rezaei SJ, Chen ML, et al
Assessing the Performance of Artificial Intelligence Models in Evaluating Inflammatory Skin Disease Severity: A Systematic Review and Meta-Analysis.
Br J Dermatol. 2025 Jun 26:ljaf250. doi: 10.1093.
PubMed Abstract available

BAI X, Flaherty KT
The Rise of New Targets in Melanoma.
Br J Dermatol. 2025 Jun 26:ljaf251. doi: 10.1093.
PubMed Abstract available

SEXTON F, O' Mahony J, Sumera S, Golchin R, et al
Culprit allergens in diabetes technology-associated allergic contact dermatitis: investigation remains challenging.
Br J Dermatol. 2025 Jun 26:ljaf245. doi: 10.1093.
PubMed

IMHOF RL, Yang E, Lehman J, Tekin B, et al
Lichen planus pemphigoides - A retrospective single-center cohort over two decades and comparison of idiopathic vs. drug-induced cases.
Br J Dermatol. 2025 Jun 25:ljaf240. doi: 10.1093.
PubMed

LEE EY, Ang YS, Leow SY, Koh MJA, et al
Mobile Inpatient Care at Home: A Pilot Programme for Paediatric Patients with Atopic Dermatitis in Singapore.
Br J Dermatol. 2025 Jun 24:ljaf246. doi: 10.1093.
PubMed

LIU T, Chang JM
Clown Nose-Like Cutaneous Metastasis.
Br J Dermatol. 2025 Jun 24:ljaf247. doi: 10.1093.
PubMed

ALANI O, Ahmed A, Haraldsdottir EL, Hoyt D, et al
The Incidence and Impact of Melanoma Subtypes in Iceland 1955-2023.
Br J Dermatol. 2025 Jun 23:ljaf248. doi: 10.1093.
PubMed

GOODERHAM M, Torres T, Imafuku S, Rademaker M, et al
Efficacy and Safety of Upadacitinib Dose Escalation and Reduction in Adult Patients With Moderate-To-Severe Atopic Dermatitis: Results of a Randomized, Blinded, Treat-To-Target, Multicenter Phase 3b/4 Study (Flex Up).
Br J Dermatol. 2025 Jun 23:ljaf236. doi: 10.1093.
PubMed Abstract available

O'REILLY P, Savarimalai R, Walsh S, Barry LA, et al
The impact of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on the health-related quality of life (HRQoL) experiences of adults with SJS/TEN: A mixed method systematic review.
Br J Dermatol. 2025 Jun 21:ljaf229. doi: 10.1093.
PubMed Abstract available

YUAN Y, Wang H, Pan M, Zheng J, et al
Exome and transcriptome analysis link calcium channel pathway aberrations to botulinum toxin A resistance in Hailey-Hailey disease.
Br J Dermatol. 2025;193:147-156.
PubMed Abstract available

KIRBY JS, Thorlacius L, Lambert J, Ciaravino V, et al
Psychometric validation and interpretation thresholds of the Hidradenitis Suppurativa Quality of Life (HiSQOL(c)) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa.
Br J Dermatol. 2025;193:93-104.
PubMed Abstract available

YOKOZEKI H, Murota H, Matsumura T
Long-term (68 weeks) administration of nemolizumab and topical corticosteroids for prurigo nodularis in patients aged >/= 13 years: efficacy and safety data from a phase II/III study.
Br J Dermatol. 2025;193:56-65.
PubMed Abstract available

HOWELLS L, Leighton P, Thomas KS, Collier F, et al
A qualitative interview study exploring patients' views and experiences of treatment for hidradenitis suppurativa in the UK.
Br J Dermatol. 2025;193:85-92.
PubMed Abstract available

GAY-MIMBRERA J, Lozano-Ojalvo D, Gomez-Arias PJ, Rivera-Ruiz I, et al
Comprehensive single-cell chromatin and transcriptomic profiling of peripheral immune cells in nonsegmental vitiligo.
Br J Dermatol. 2025;193:115-124.
PubMed Abstract available

CHANG CY, Chan K, Chen HC, Lai CC, et al
Atopic dermatitis epidemiological research methodology: a global scoping review.
Br J Dermatol. 2025 Jun 19:ljaf238. doi: 10.1093.
PubMed Abstract available

KAHLER S, Primiero C, Jayasinghe D, Mothershaw A, et al
Unpredictable interdependence of invasive and in situ melanoma.
Br J Dermatol. 2025 Jun 19:ljaf235. doi: 10.1093.
PubMed

TAN JY, Marlow L, Phillips C, McPherson T, et al
Chronic inflammatory skin conditions in adolescents and their impact on intimate relationships - a quantitative and qualitative study.
Br J Dermatol. 2025 Jun 13:ljaf228. doi: 10.1093.
PubMed Abstract available

XIAO H, Ding Y, Shen M, Chen X, et al
Menopausal Age, Hormone Therapy, and Risk of Psoriasis: A Prospective Cohort Study applying Inverse Probability of Treatment Weighting Analysis.
Br J Dermatol. 2025 Jun 10:ljaf222. doi: 10.1093.
PubMed

SIA T, Li S, Zhong X, Park C, et al
Acitretin chemoprevention in non-melanoma skin cancer patients with chronic hematopoietic disease: findings from three independent databases.
Br J Dermatol. 2025 Jun 10:ljaf221. doi: 10.1093.
PubMed

LIU Z, Zhang Y, Wang K, Xie F, et al
Early diagnosis model of mycosis fungoides and five inflammatory skin diseases based on multi-modal data-based convolutional neural network.
Br J Dermatol. 2025 Jun 4:ljaf212. doi: 10.1093.
PubMed Abstract available

LIU X, McBride JD
Unmethylated PRAME DNA in Tissue and Plasma: A Promising Marker for Melanoma.
Br J Dermatol. 2025 Jun 3:ljaf217. doi: 10.1093.
PubMed

DANESH K, Adler BL, Vecerek N
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus.
Br J Dermatol. 2025 Jun 3:ljaf215. doi: 10.1093.
PubMed

May 2025

BRUSTAD N, Wang T, Chen L, Kaiser H, et al
Prenatal high-dose vitamin D supplementation and childhood atopic dermatitis until age 6 years: A secondary analysis of a randomized clinical trial.
Br J Dermatol. 2025 May 30:ljaf208. doi: 10.1093.
PubMed

BOOSTANI M, Wortsman X, Pellacani G, Cantisani C, et al
Dermoscopy-guided high-frequency ultrasound for preoperative assessment of basal cell carcinoma lateral margins: A pilot study.
Br J Dermatol. 2025 May 29:ljaf209. doi: 10.1093.
PubMed

LAIMER M, South AP, Mayr E, Kitzmueller S, et al
Efficacy and Safety of Rigosertib in Patients with Recessive Dystrophic Epidermolysis Bullosa Associated Advanced/Metastatic Cutaneous Squamous Cell Carcinoma.
Br J Dermatol. 2025 May 29:ljaf205. doi: 10.1093.
PubMed Abstract available

TYSON-CARR J, Leng J, Scott M, Adams S, et al
Body-site specific associations between human skin microbiome composition and psychological wellbeing.
Br J Dermatol. 2025 May 26:ljaf177. doi: 10.1093.
PubMed Abstract available

GARGIULO L, Costanzo A
Age of Onset Matters: Tildrakizumab Response in Early vs Late-Onset Psoriasis.
Br J Dermatol. 2025 May 23:ljaf186. doi: 10.1093.
PubMed

MCGRATH JA, Mellerio JE
The classification of Ichthyosis morphs into Epidermal Differentiation Disorders.
Br J Dermatol. 2025 May 23:ljaf197. doi: 10.1093.
PubMed

LEE JYW, Mahil SK
Systemic inflammation and psoriasis: unpicking a complex relationship.
Br J Dermatol. 2025 May 23:ljaf203. doi: 10.1093.
PubMed

ANDREW PV, Williams SF, Brown K, Chittock J, et al
Topical supplementation with physiologic lipids rebalances the stratum corneum ceramide profile and strengthens skin barrier function in adults predisposed to atopic dermatitis.
Br J Dermatol. 2025 May 23:ljaf200. doi: 10.1093.
PubMed Abstract available

MAHO-VAILLANT M, Lemieux A, Arnoult C, Lebourgeois L, et al
Prevalence and pathogenic activity of anti-desmocollin-3 antibodies in patients with pemphigus vulgaris and pemphigus foliaceus.
Br J Dermatol. 2025;192:1072-1082.
PubMed Abstract available

KIM BR, Kim G, Jin SP, Choi CW, et al
Causal association between polyunsaturated fatty acids and acne: a two-sample Mendelian randomization study.
Br J Dermatol. 2025;192:1106-1114.
PubMed Abstract available

MURRELL DF, Bodemer C, Bruckner AL, Cunningham T, et al
Long-term safety and efficacy of Oleogel-S10 (birch bark extract) in epidermolysis bullosa: 24-month results from the phase III EASE study.
Br J Dermatol. 2025;192:1007-1017.
PubMed Abstract available

APFELBACHER C, Bewley A, Molin S, Fargnoli MC, et al
Prevalence of chronic hand eczema in adults: a cross-sectional survey of over 60 000 respondents from the general population of Canada, France, Germany, Italy, Spain and the UK.
Br J Dermatol. 2025;192:1047-1054.
PubMed Abstract available

DIMITRION PM, Krevh R, Veenstra J, Ge J, et al
High-throughput proteomics identifies inflammatory proteins associated with disease severity and genetic ancestry in patients with hidradenitis suppurativa.
Br J Dermatol. 2025;192:1063-1071.
PubMed Abstract available

POWELL JB, Dhesi JK, Harwood CA, McGrath EJ, et al
How do we avoid over-treating skin cancer in people with severe frailty and limited life expectancy?
Br J Dermatol. 2025 May 15:ljaf174. doi: 10.1093.
PubMed

DA ROSA GP, Santos JV, Cerejeira A, Matos P, et al
Patterns of hospitalizations due to bacterial skin and soft tissue infections: a retrospective observational study from a Portuguese national registry.
Br J Dermatol. 2025 May 15:ljaf157. doi: 10.1093.
PubMed

DOELEMAN T, Beljaards ESM, Ottevanger R, Jansen P, et al
Added value of pathology consultations in cutaneous lymphomas: a 2-year review from the Dutch national referral and expertise centre.
Br J Dermatol. 2025 May 14:ljaf184. doi: 10.1093.
PubMed Abstract available

CHEN JQ, Zheng M, Yin WH, Wang P, et al
Safety and efficacy of the selective TYK2/JAK1 inhibitor TLL-018 in moderate-to-severe plaque psoriasis: A phase 1b, randomized, double-blind, placebo-controlled study.
Br J Dermatol. 2025 May 14:ljaf185. doi: 10.1093.
PubMed Abstract available

ARMSTRONG AW, Blauvelt A, Lebwohl M, Asahina A, et al
Efficacy and safety of tildrakizumab in patients with early- vs late-onset psoriasis.
Br J Dermatol. 2025 May 14:ljaf171. doi: 10.1093.
PubMed Abstract available

YANG HW, Chen YH, To SY, Wen YL, et al
Hormone Therapy and Increased Risk of Psoriasis in Reproductive-age and Postmenopausal Women: A Nationwide Cohort Study and Target Trial Emulation.
Br J Dermatol. 2025 May 9:ljaf179. doi: 10.1093.
PubMed Abstract available

WANG Y, Xu G, Xia H
Targeting the MAPK Pathway for NRAS Mutant Melanoma: From Mechanism to Clinic.
Br J Dermatol. 2025 May 9:ljaf178. doi: 10.1093.
PubMed Abstract available

DRUCKER AM, Walwyn C, Chu C, Yiu ZZN, et al
Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis.
Br J Dermatol. 2025 May 7:ljaf166. doi: 10.1093.
PubMed

WHITEMAN DC
Melanoma in England: incidence is up, mortality is down.
Br J Dermatol. 2025 May 7:ljaf175. doi: 10.1093.
PubMed

MORTIMORE AM, McMeniman E
Reassuring results from skin cancer risk in Swedish patients with vitiligo and alopecia areata.
Br J Dermatol. 2025 May 6:ljaf118. doi: 10.1093.
PubMed

FOWLER JC, Sood RK, Coltart G, Lai C, et al
The mutation burden of narrowband ultraviolet B phototherapy (NB-UVB) in human skin; relevance to NB-UVB lifetime exposures and skin cancer surveillance.
Br J Dermatol. 2025 May 3:ljaf173. doi: 10.1093.
PubMed Abstract available

KIRCIK L, Tsianakas A, Valenzuela F, Mikol V, et al
Efficacy and Safety of Rilzabrutinib in Patients With Moderate-to-Severe Atopic Dermatitis: 16-Week Results From a Proof-of-Concept Phase II Clinical Trial.
Br J Dermatol. 2025 May 3:ljaf156. doi: 10.1093.
PubMed Abstract available

ZHANG WW, Ke LF, Chen Y, Wu CY, et al
Methylation-Based Test for Diagnosis of Benign and Malignant Melanocytoma.
Br J Dermatol. 2025 May 2:ljaf169. doi: 10.1093.
PubMed Abstract available

GILLESPIE J, Bash GN, Jacobson ME, Latour E, et al
Harmonizing Measurement of Eczema Control- Mapping Scores Between the Atopic Dermatitis Control Tool and The Recap of Atopic Eczema Instrument.
Br J Dermatol. 2025 May 2:ljaf167. doi: 10.1093.
PubMed Abstract available

LU G, Chambers S, Cepica T, Xie L, et al
Erythema and scale in cutaneous lupus erythematosus significantly impacts patient quality of life and disease course impression.
Br J Dermatol. 2025 May 2:ljaf165. doi: 10.1093.
PubMed

April 2025

JIANG X, Mortlock RD, Lomakin IB, Zhou J, et al
Autosomal dominant SLURP1 variants cause palmoplantar keratoderma and progressive symmetric erythrokeratoderma.
Br J Dermatol. 2025;192:896-906.
PubMed Abstract available

PATHMARAJAH P, Eid E, Nazaroff J, So J, et al
Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa.
Br J Dermatol. 2025;192:917-925.
PubMed Abstract available

SCHELL SL, Sennett ML, Feehan RP, Wallace TE, et al
Pilot study of topical ruxolitinib demonstrates efficacy and blunting of heterogeneous inflammatory processes in mild hidradenitis suppurativa.
Br J Dermatol. 2025;192:845-856.
PubMed Abstract available

LIU Y, Liu Z, Li D, He X, et al
Emerging role of regulatory T cells in the immunopathogenesis of vitiligo and implications for treatment.
Br J Dermatol. 2025;192:796-806.
PubMed Abstract available

SILVERBERG JI, Dodiuk-Gad R, Takaoka R, Tan J, et al
Atopic dermatitis starting in childhood has a stronger impact on adults: results from the "Scars of Life" international project in 27 countries.
Br J Dermatol. 2025 Apr 26:ljaf158. doi: 10.1093.
PubMed

LEMARCQ L, Reynaert V, Van den Steen E, Evers-Lebrun C, et al
Outcome Measures for Interdisciplinary Care in Immune-mediated Inflammatory Skin Diseases (skIMIDs): A Scoping Review.
Br J Dermatol. 2025 Apr 18:ljaf153. doi: 10.1093.
PubMed Abstract available

NASLUND-KOCH C, Kvist-Hansen A, Bojesen SE, Skov L, et al
Low-grade systemic inflammation is associated with risk of psoriasis in a general population study of more than 100,000 individuals.
Br J Dermatol. 2025 Apr 18:ljaf147. doi: 10.1093.
PubMed Abstract available

DUGOURD PM, Guardoli D, Fontas E, Marie-Luce S, et al
Promoting Repigmentation after Epidermal cell suspension grafting and preVENTing the loss of melanocytes using topical ruxolitinib for vitiligo in resistant areas (PREVENT). A prospective monocentric interventional double-blind study.
Br J Dermatol. 2025 Apr 17:ljaf143. doi: 10.1093.
PubMed

FARIYIKE O, Johnson NA, Van Bodegraven B, Quirke K, et al
The role of limited life expectancy in personalised treatment decisions: 1 in 6 patients aged 80+ with a basal cell carcinoma die within 2 years of diagnosis in England.
Br J Dermatol. 2025 Apr 15:ljaf135. doi: 10.1093.
PubMed

ZHU J, Abuabara K
Complex comorbidities: Could a diabetes drug help prevent atopic dermatitis?
Br J Dermatol. 2025 Apr 15:ljaf131. doi: 10.1093.
PubMed

CHEN J, Liu X, Bai Y, Tang X, et al
Tonsillar Microbiota Alterations Contribute to Immune Responses in Psoriasis by Skewing Aged Neutrophils.
Br J Dermatol. 2025 Apr 15:ljaf134. doi: 10.1093.
PubMed Abstract available

KARPONIS D, van Bodegraven B, Mistry K, Nikolaou V, et al
Incidence and mortality of melanoma in situ and malignant melanoma in England between 2001 and 2020.
Br J Dermatol. 2025 Apr 15:ljaf136. doi: 10.1093.
PubMed Abstract available

PILERI A, Zengarini C
Harnessing Extracorporeal Photopheresis to Trigger Immunogen Cell Death: A Bounty on Cutaneous Lymphoma Cells.
Br J Dermatol. 2025 Apr 12:ljaf138. doi: 10.1093.
PubMed

HUAI P, Xing P, Yang Y, Kong Y, et al
Global burden of skin and subcutaneous diseases: an update from the Global Burden of Disease Study 2021.
Br J Dermatol. 2025 Apr 11:ljaf071. doi: 10.1093.
PubMed

FALTOT L, Donzel M, Chidiac G, Balme B, et al
Evaluation of the anti-CCR4 monoclonal antibody Mogamulizumab in advanced cutaneous T-cell lymphomas and with large cell transformation.
Br J Dermatol. 2025 Apr 7:ljaf125. doi: 10.1093.
PubMed

MAZEREEUW-HAUTIER J, Paller AS, O'Toole E, Dreyfus I, et al
Management of congenital ichthyoses: Guidelines of care: Part Two: 2024 Update.
Br J Dermatol. 2025 Apr 7:ljaf077. doi: 10.1093.
PubMed Abstract available

WANG J, Hennessey D, Iyer A, O'Keefe S, et al
Transcriptomic skin niches in systemic sclerosis underpins a role for mitochondrial dysfunction.
Br J Dermatol. 2025 Apr 2:ljaf119. doi: 10.1093.
PubMed

ISKANDAR RJ, Tadrous M, Nguyen P, Dolovich L, et al
Characteristics of patients seeking skin-related minor ailment pharmacy services in Ontario, Canada: A population-based cross-sectional study.
Br J Dermatol. 2025 Apr 2:ljaf092. doi: 10.1093.
PubMed

SARASWAT N, Tripathy DM, Adhau RW, Tripathy A, et al
Furuncular Myiasis in the skin of colour.
Br J Dermatol. 2025 Apr 1:ljaf114. doi: 10.1093.
PubMed

March 2025

MAZEREEUW-HAUTIER J, Paller AS, Dreyfus I, Sprecher E, et al
Management of congenital ichthyoses: Guidelines of care: Part One: 2024 Update.
Br J Dermatol. 2025 Mar 28:ljaf076. doi: 10.1093.
PubMed Abstract available

ALEXANDER H, Murryam S, Kezic S, Motazedi E, et al
Methotrexate and Cyclosporin Improve Skin Biomarkers in Paediatric Atopic Dermatitis: Results from the TREatment of Severe Atopic Eczema Trial.
Br J Dermatol. 2025 Mar 27:ljaf115. doi: 10.1093.
PubMed

VESTERGAARD C
Air Pollution and Atopic Dermatitis: Critical Windows of Risk in Early Life.
Br J Dermatol. 2025 Mar 24:ljaf109. doi: 10.1093.
PubMed

BAGOT M
Therapeutic advances for Cutaneous T Cell Lymphoma.
Br J Dermatol. 2025 Mar 22:ljaf105. doi: 10.1093.
PubMed Abstract available

LACKNER A, Burner T, Brandner M, Dey S, et al
Evidence of Immunogenic Cell Death (ICD) and ICD-dependent Dendritic Cell Activation Induced by Extracorporeal Photopheresis in Patients with leukemic forms of cutaneous T cell lymphoma.
Br J Dermatol. 2025 Mar 20:ljaf102. doi: 10.1093.
PubMed Abstract available

LEE CN, Hsieh MH, Chen CY, Yang CC, et al
Risk of Herpes Zoster and Postherpetic Neuralgia in Patients with Psoriasis Treated with Biologics: A nationwide study using target trial emulation framework.
Br J Dermatol. 2025 Mar 20:ljaf101. doi: 10.1093.
PubMed Abstract available

DE LA IGLESIA MARTIN J, Martin Vera J, Tubau Prims C
Dermatitis cruris pustulosa et atrophicans.
Br J Dermatol. 2025 Mar 20:ljaf103. doi: 10.1093.
PubMed

AHMADY S, Mosterd K, Jansen MHE, Kelleners-Smeets NWJ, et al
Patient preferences for the treatment of Bowen disease.
Br J Dermatol. 2025;192:653-659.
PubMed Abstract available

KIMBALL AB, Bechara FG, Badat A, Giamarellos-Bourboulis EJ, et al
Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trial.
Br J Dermatol. 2025;192:629-640.
PubMed Abstract available

LEAR JT, Harwood CA, Hasan Z, Kentley J, et al
Topical application of the Hedgehog inhibitor patidegib in patients with Gorlin syndrome: a phase II trial.
Br J Dermatol. 2025;192:611-617.
PubMed Abstract available

RASTRICK J, Edwards H, Ferecsko AS, Le Friec G, et al
The roles of interleukin (IL)-17A and IL-17F in hidradenitis suppurativa pathogenesis: evidence from human in vitro preclinical experiments and clinical samples.
Br J Dermatol. 2025;192:660-671.
PubMed Abstract available

HUA VK, Chang J, Laxer RM, Broderick L, et al
Disabling pansclerotic morphoea: a century of discovery.
Br J Dermatol. 2025;192:585-596.
PubMed Abstract available

WALBURN J, Norton S, Sarkany R, Canfield M, et al
A personalized and systematically designed adherence intervention improves photoprotection in adults with xeroderma pigmentosum (XP): results of the XPAND randomized controlled trial.
Br J Dermatol. 2025;192:728-737.
PubMed Abstract available

NAKAMIZO S, Kabashima K
Cutaneous Granulomas: Mechanisms, Cellular Interactions, and Therapeutic Insights.
Br J Dermatol. 2025 Mar 13:ljaf096. doi: 10.1093.
PubMed Abstract available

MIRANDA BH, Shahid S, Correiro A, Zhang J, et al
St Andrews Referral Delay in Skin Cancer (StARDISC): A study of keratinocyte skin cancer time to treatment, growth, invasiveness, British Association of Dermatologists risk factors and excision adequacy.
Br J Dermatol. 2025 Mar 13:ljaf097. doi: 10.1093.
PubMed Abstract available

LI T, Tao R, Yang L, Wan Z, et al
Upadacitinib outperforms dupilumab in restoring the fungal microbiome in atopic dermatitis.
Br J Dermatol. 2025 Mar 12:ljaf095. doi: 10.1093.
PubMed

SU T, Yu Y, Su Z, Lu Y, et al
Rapid improvements in Kaposi sarcoma with metformin: a report of two cases.
Br J Dermatol. 2025 Mar 11:ljaf090. doi: 10.1093.
PubMed

ZHANG Q, Liu G, Jing L, Aghayants S, et al
The Landscape of m6A RNA Methylation in Skin Diseases.
Br J Dermatol. 2025 Mar 10:ljaf087. doi: 10.1093.
PubMed Abstract available

WEN YL, Hsu WT, Chen YH, Kao HH, et al
Sodium-glucose Cotransporter 2 Inhibitors and Inverse Risk of New-onset Atopic Dermatitis in Diabetic Population: a Nationwide, Active-comparator Study.
Br J Dermatol. 2025 Mar 4:ljaf086. doi: 10.1093.
PubMed Abstract available

KOCHI Y, Togawa Y, Yamazaki Y, Yamamoto Y, et al
Anatomical distribution of acral lentiginous melanoma in the hand and nail among Japanese individuals.
Br J Dermatol. 2025 Mar 4:ljaf070. doi: 10.1093.
PubMed

VON SCHUCKMANN LA, Khosrotehrani K
Haematological cancers and skin cancer: statistics from the Netherlands.
Br J Dermatol. 2025 Mar 1:ljaf081. doi: 10.1093.
PubMed

February 2025

COSTANZA M, Giordano C, von Brunneck AC, Zhao J, et al
Preclinical in vitro and in vivo evidence for CD74-targeting as effective treatment strategy for cutaneous T cell lymphomas.
Br J Dermatol. 2025 Feb 27:ljaf001. doi: 10.1093.
PubMed Abstract available

ACKERMANN DM, Bell KJL
Setting the melanoma research agenda for all end-users: the need to include patient, clinician, and policy perspectives.
Br J Dermatol. 2025 Feb 27:ljaf082. doi: 10.1093.
PubMed

NARDIN C, Vernerey D, Aubin F
Ipilimumab + nivolumab combination or nivolumab monotherapy as first-line treatment in patients with metastatic melanoma: conclusions from a real-world French national cohort.
Br J Dermatol. 2025 Feb 27:ljaf080. doi: 10.1093.
PubMed

MISTRY K, Srimudkul O, Patel M, Ragan J, et al
Patient research priorities in melanoma: a national qualitative interview study.
Br J Dermatol. 2025 Feb 27:ljaf048. doi: 10.1093.
PubMed Abstract available

ROY SF, Agim NG, Mir A, Couts KL, et al
Congenital melanocytic nevi initiated by BRAF fusion oncogene with firmness, pruritus, and desmoplastic stroma.
Br J Dermatol. 2025 Feb 27:ljaf061. doi: 10.1093.
PubMed Abstract available

LIN LH, Lee CC, Hwang MM, Jung CR, et al
Fine particulate matter exposure and incident atopic dermatitis: A birth cohort study.
Br J Dermatol. 2025 Feb 26:ljaf075. doi: 10.1093.
PubMed Abstract available

KROAH-HARTMAN M, Lee JYW, Dooley N, Tan WR, et al
Environmental triggers of psoriasis: insights from a UK patient-reported cohort (mySkin).
Br J Dermatol. 2025 Feb 25:ljaf073. doi: 10.1093.
PubMed

DELCOIGNE B, Lysell J, Askling J
Incidence, stage and outcome of melanoma, keratinocyte and other cancers in individuals with vitiligo or alopecia: intraindividual or familial risks?
Br J Dermatol. 2025 Feb 25:ljaf074. doi: 10.1093.
PubMed Abstract available

OTTEVANGER R, Vermeer MH
Cutaneous T-cell lymphoma in Australia: what drives geospatial?
Br J Dermatol. 2025 Feb 22:ljaf026. doi: 10.1093.
PubMed

WANG Z, Liu J, Wechsberg O, Liang L, et al
Variants in KLF4 affecting residue Asp441 cause an autosomal dominant syndromic ichthyosis.
Br J Dermatol. 2025 Feb 19:ljaf062. doi: 10.1093.
PubMed Abstract available

PERIS K
Patidegib: a novel, promising treatment for basal cell carcinoma lesions in patients with Gorlin syndrome.
Br J Dermatol. 2025 Feb 19:ljae515. doi: 10.1093.
PubMed

GNIADECKI R, Guenova E, Querfeld C, Nicolay JP, et al
Haematogenous seeding in mycosis fungoides and Sezary syndrome: current evidence and clinical implications.
Br J Dermatol. 2025;192:381-389.
PubMed Abstract available

PHILIPP-DORMSTON WG, Bruckner M, Hoffmann M, Bae M, et al
Artificial daylight photodynamic therapy using methyl aminolaevulinate in a real-world setting in Germany: results from the noninterventional study ArtLight.
Br J Dermatol. 2025;192:510-519.
PubMed Abstract available

WEHKAMP U, Pietzka S, Kotrova M, Jost M, et al
Mycosis fungoides: differentiation from inflammation and detection of circulating tumour cells with the EuroClonality next-generation sequencing assay.
Br J Dermatol. 2025;192:492-500.
PubMed Abstract available

DONHAUSER T, Gabes M, Masur C, Kamudoni P, et al
Longitudinal validity of the Hyperhidrosis Quality of Life Index (HidroQoL(c)) in a phase IIIb clinical trial population with hyperhidrosis: responsiveness and meaningful change.
Br J Dermatol. 2025;192:450-457.
PubMed Abstract available

SWIDERSKI M, Vinogradova Y, Knaggs RD, Harman K, et al
Association between drugs and vaccines commonly prescribed to older people and bullous pemphigoid: a case-control study.
Br J Dermatol. 2025;192:440-449.
PubMed Abstract available

KIM SR, Koh SJ, Park H
Association of childhood obesity or weight change with early-onset follicular occlusion triad in children.
Br J Dermatol. 2025;192:430-439.
PubMed Abstract available

PLANELLA-FONTANILLAS N, Bosch-Amate X, Jimenez Anton A, Moreno-Vilchez C, et al
Real-world evaluation of the effectiveness and safety of dupilumab in bullous pemphigoid: an ambispective multicentre case series.
Br J Dermatol. 2025;192:501-509.
PubMed Abstract available

SZONDI DC, Crompton RA, Oon L, Subramaniam N, et al
A role for Arginase in skin epithelial differentiation and anti-microbial peptide production.
Br J Dermatol. 2025 Feb 14:ljaf057. doi: 10.1093.
PubMed Abstract available

ZOUBOULIS CC, Deloche C, Skayem C, Leclerc-Mercier S, et al
Global study of 17,009 women reveal significant skin condition changes associated with irregular menstrual cycles.
Br J Dermatol. 2025 Feb 11:ljae484. doi: 10.1093.
PubMed

LOPEZ S, Thakker S, Minkis K
Beyond the Diagnosis: A Skin of Color Patient's Journey with Acral Lentiginous Melanoma.
Br J Dermatol. 2025 Feb 6:ljaf047. doi: 10.1093.
PubMed

VON KOBYLETZKI L, Svensson A
Patient-reported outcome measures are highly needed for patients with skin of colour with atopic dermatitis.
Br J Dermatol. 2025 Feb 4:ljaf043. doi: 10.1093.
PubMed

FREW JW
Unravelling the complex pathogenesis of hidradenitis suppurativa.
Br J Dermatol. 2025;192.
PubMed Abstract available

PETUKHOVA L, Colvin A, Koerts NDK, Horvath B, et al
Leveraging genotypes and phenotypes to implement precision medicine in hidradenitis suppurativa management.
Br J Dermatol. 2025;192.
PubMed Abstract available

SAYED CJ, Shams RB, Midgette B, Garg A, et al
An evolutionary tale on clinical trials in hidradenitis suppurativa.
Br J Dermatol. 2025;192.
PubMed Abstract available

January 2025

LEDUCQ S, Fong WCG, Williams HC, Bradshaw L, et al
Reporting of concomitant and rescue topical therapies in atopic dermatitis randomised controlled trials evaluating a systemic treatment: a scoping review.
Br J Dermatol. 2025 Jan 30:ljaf031. doi: 10.1093.
PubMed Abstract available

ALVES C
Orismilast for moderate-to-severe atopic dermatitis: the potential therapeutic value of a new oral pharmacological alternative.
Br J Dermatol. 2025 Jan 30:ljaf042. doi: 10.1093.
PubMed

GNIADECKI R
Chaperoning a Cure: Unexpected Role of CD74 in Cutaneous T-cell lymphoma.
Br J Dermatol. 2025 Jan 29:ljaf040. doi: 10.1093.
PubMed

KANEDA E, Koguchi-Yoshioka H, Nimura K, Hattori S, et al
Genotype-phenotype correlation for skin and neuropsychiatric features in tuberous sclerosis complex.
Br J Dermatol. 2025 Jan 28:ljaf038. doi: 10.1093.
PubMed

WARREN RB, Lebwohl M, Thaci D, Gooderham M, et al
Bimekizumab efficacy and safety through 3 years in patients with moderate to severe plaque psoriasis: Long-term results from the BE RADIANT phase 3b trial open-label extension period.
Br J Dermatol. 2025 Jan 25:ljaf032. doi: 10.1093.
PubMed Abstract available

PILIANG M, Soung J, King B, Shapiro J, et al
Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alop
Br J Dermatol. 2025;192:215-227.
PubMed Abstract available

GARG A, Burge R, Cohee A, Wallinger H, et al
Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa.
Br J Dermatol. 2025;192:261-268.
PubMed Abstract available

ZHU Z, Zhong X, Luo Z, Liu M, et al
Global, regional and national burdens of acne vulgaris in adolescents and young adults aged 10-24 years from 1990 to 2021: a trend analysis.
Br J Dermatol. 2025;192:228-237.
PubMed Abstract available

PERALS C, le Jan S, Muller C, Le Naour R, et al
Polarization of circulating follicular helper T cells correlates with bullous pemphigoid severity.
Br J Dermatol. 2025;192:283-292.
PubMed Abstract available

EGGERMONT CJ, Hollatz A, Wakkee M, Louwman M, et al
Skin cancer risk in over 200.000 patients with haematologic malignancies in 30 years; a nationwide population-based study in the Netherlands.
Br J Dermatol. 2025 Jan 24:ljaf027. doi: 10.1093.
PubMed Abstract available

Correction to: Microbiome characterization of skin biopsies in Spanish patients with hidradenitis suppurativa shows a decrease in D1 and H1 lineages of Cutibacterium acnes.
Br J Dermatol. 2025 Jan 24:ljaf029. doi: 10.1093.
PubMed

BARKER JN, Casanova E, Choon SE, Foley P, et al
Global Delphi consensus on treatment goals for generalised pustular psoriasis.
Br J Dermatol. 2025 Jan 23:ljae491. doi: 10.1093.
PubMed Abstract available

SMITH MJ, Peach H, Keohane S, Lear J, et al
Melanoma: Assessment and Management summary of 2022 update of the NICE guidelines.
Br J Dermatol. 2025 Jan 21:ljaf016. doi: 10.1093.
PubMed Abstract available

ANDERSON ADG, Shirwac HF, Morgan H, Greenish H, et al
Real-World Melanoma Miss-Rate In An NHS Hospital Dermatology Service. A Retrospective Study.
Br J Dermatol. 2025 Jan 16:ljaf024. doi: 10.1093.
PubMed

ALABAS OA, Mason KJ, Yiu ZZN, Smith CH, et al
Age and biologic survival in patients with moderate-to-severe psoriasis: A cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
Br J Dermatol. 2025 Jan 10:ljaf017. doi: 10.1093.
PubMed Abstract available

HARTFORD C, Alexis A, Wang Z, Levit NA, et al
Development of novel patient-reported outcome instruments to assess atopic dermatitis-associated dyspigmentation and xerosis in patients with skin of colour.
Br J Dermatol. 2025 Jan 10:ljae494. doi: 10.1093.
PubMed Abstract available

PUIG L
Post-switching discontinuation of biosimilars in psoriasis: registry analyses fall short in addressing real-world biases.
Br J Dermatol. 2025 Jan 7:ljaf003. doi: 10.1093.
PubMed

CHENG JW, Li JH
Squamous cell carcinoma arising from lichen planus.
Br J Dermatol. 2025 Jan 7:ljaf007. doi: 10.1093.
PubMed

MCGRATH JA, Kabashima K
Unlocking the skin's immunological secrets: antibodies and new topical vaccination strategies.
Br J Dermatol. 2025 Jan 7:ljaf014. doi: 10.1093.
PubMed

SILVERBERG JI, Eichenfield LF, Blauvelt A, Irvine AD, et al
Orismilast, a PDE4B/D inhibitor, in moderate-to-severe atopic dermatitis: Efficacy and safety from a multicenter, randomized, placebo-controlled, phase 2b dose-ranging study (ADESOS).
Br J Dermatol. 2025 Jan 7:ljae507. doi: 10.1093.
PubMed Abstract available

December 2024

PLACKE JM, Bottek J, Varaljai R, Shannan B, et al
Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanoma.
Br J Dermatol. 2024 Dec 31:ljae433. doi: 10.1093.
PubMed Abstract available

PATRA V, Wolf P
Skin microbiome and polymorphous light eruption.
Br J Dermatol. 2024 Dec 26:ljae513. doi: 10.1093.
PubMed

TAKASE K, Komatsu-Fujii T, Kogame T, Otsuka A, et al
Tinea corporis at the injection site of interleukin-17 inhibitor in psoriasis vulgaris.
Br J Dermatol. 2024 Dec 26:ljae511. doi: 10.1093.
PubMed

CHEN Z, Wang Y, Wang R
Generalized granulomatous slack skin.
Br J Dermatol. 2024 Dec 25:ljae508. doi: 10.1093.
PubMed

CARRASCOSA JM
Optimizing dosing in atopic dermatitis therapy: Looking for the cream of the crop.
Br J Dermatol. 2024 Dec 25:ljae514. doi: 10.1093.
PubMed

IWASAWA O, Ikegami M, Miyagawa T, Morita H, et al
Association of genetic alterations with prognosis in extramammary Paget disease: insights into the involvement of somatic CDKN2A variants in patients with a poor prognosis.
Br J Dermatol. 2024;192:46-54.
PubMed Abstract available

BONTOUX C, Badrignans M, Afach S, Sbidian E, et al
Pustular mycosis fungoides has a poor outcome: a multicentric clinicopathological and molecular case series.
Br J Dermatol. 2024;192:125-134.
PubMed Abstract available

ELEFTHERIADOU V, Ahmed A, Nesnas J, Nagra R, et al
The lifetime risk and impact of vitiligo across sociodemographic groups: a UK population-based cohort study.
Br J Dermatol. 2024;192:63-71.
PubMed Abstract available

LI J, Wang Y, Niu X, Xing J, et al
Downregulation of lysine 2-hydroxyisobutyrylation of ErbB3 binding protein 1 at amino acid 210 promotes keratinocyte proliferation via induction of transcription initiation factor IA-mediated rRNA synthesis.
Br J Dermatol. 2024;192:92-103.
PubMed Abstract available

Correction to: Severity rating of specific skin lesions in hidradenitis suppurativa: the patient perspective.
Br J Dermatol. 2024 Dec 23:ljae474. doi: 10.1093.
PubMed

PRAJAPATI VH, Seyger MMB, Wilsmann-Theis D, Szakos E, et al
Guselkumab for the treatment of moderate-to-severe plaque psoriasis in pediatric patients: results of the phase 3, randomized, placebo-controlled PROTOSTAR study.
Br J Dermatol. 2024 Dec 21:ljae502. doi: 10.1093.
PubMed Abstract available

PREIS S, Biedermann T, Zink A
Unseen Spaces: Psoriasis Inversa Between the Toes.
Br J Dermatol. 2024 Dec 21:ljae500. doi: 10.1093.
PubMed

BADAWY H, Harvey J, Rajan N, Stuart B, et al
Changes in skin research funding: the emergence of environmental sustainability criteria in the research competition assessment process.
Br J Dermatol. 2024 Dec 20:ljae503. doi: 10.1093.
PubMed

CHEN L, Tan M, Li T, Zhu L, et al
Rapid and sustained response of stubborn guttate psoriasis to ustekinumab: A 52-week, two-center, one-arm, observational study.
Br J Dermatol. 2024 Dec 18:ljae481. doi: 10.1093.
PubMed Abstract available

WHITEMAN DC, Pandeya N, Olsen CM
Differences in mean age at diagnosis of invasive melanoma for men and women, by anatomic site, thickness, and subtype.
Br J Dermatol. 2024 Dec 17:ljae482. doi: 10.1093.
PubMed Abstract available

MITRA R, Hale TK, Fitzsimons HL, Gray C, et al
A novel three-dimensional model of Infantile Haemangioma.
Br J Dermatol. 2024 Dec 17:ljae483. doi: 10.1093.
PubMed Abstract available

LYNCH M
Beyond the Algorithm: Ethical Challenges in AI-Driven Skin Cancer Diagnosis.
Br J Dermatol. 2024 Dec 16:ljae490. doi: 10.1093.
PubMed

MORTATO E, Talamonti M, Paganini C, Belcastro A, et al
Comment on "A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council"- A case of Rhabdomyolysis Induced by Upadacitinib.
Br J Dermatol. 2024 Dec 13:ljae485. doi: 10.1093.
PubMed

LOUVEAU B, Jouenne F, Ram-Wolff C, Mancini M, et al
Comment on 'Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder' by Wobser et al.
Br J Dermatol. 2024 Dec 13:ljae487. doi: 10.1093.
PubMed

DOUSSET L, Khosrotehrani K
A new frontier in drug discovery for skin cancer through electronic medical records.
Br J Dermatol. 2024 Dec 13:ljae489. doi: 10.1093.
PubMed

BERESFORD-WYLIE B, Ashcroft S, Gaglani B, Green A, et al
Integrating artificial intelligence into skin cancer pathways; the opportunities and obstacles.
Br J Dermatol. 2024 Dec 11:ljae480. doi: 10.1093.
PubMed

CHO SI, Na JI
Long-term observation to determine durable efficacy and safety of novel paediatric atopic dermatitis treatment, nemolizumab.
Br J Dermatol. 2024 Dec 10:ljae479. doi: 10.1093.
PubMed

SINKKO H, Olah P, Yang Y, Maia G, et al
Taxonomic and functional profiling of skin microbiome in psoriasis.
Br J Dermatol. 2024 Dec 9:ljae471. doi: 10.1093.
PubMed

SHAH SFH, O'Toole EA
Biologics in Congenital Ichthyosis - an Incomplete Fix.
Br J Dermatol. 2024 Dec 6:ljae475. doi: 10.1093.
PubMed

CAMPBELL BA, Baade PD, Dasgupta P, Cameron JK, et al
Geospatial analyses demonstrate variation of cutaneous T-cell lymphomas across Australia, providing insights into possible causes.
Br J Dermatol. 2024 Dec 6:ljae476. doi: 10.1093.
PubMed Abstract available

WEIDINGER S, Bewley A, Hong HC, Silvestre JF, et al
Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitis.
Br J Dermatol. 2024 Dec 5:ljae439. doi: 10.1093.
PubMed Abstract available

MCGRATH JA
Recently discovered roles for macrophages in human skin development.
Br J Dermatol. 2024 Dec 4:ljae473. doi: 10.1093.
PubMed

November 2024

IGARASHI A, Katsunuma T, Nagano Y, Komazaki H, et al
Long-term (68 weeks) administration of nemolizumab in paediatric patients aged 6-12 years with atopic dermatitis with moderate-to-severe pruritus: efficacy and safety data from a phase III study.
Br J Dermatol. 2024 Nov 28:ljae458. doi: 10.1093.
PubMed Abstract available

KARINE B, Mortier L, Dereure O, Dalac S, et al
The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab versus nivolumab in a real-world setting.
Br J Dermatol. 2024 Nov 28:ljae470. doi: 10.1093.
PubMed Abstract available

WOLBER AK, Jayasinghe D, Betz-Stablein B, Janda M, et al
Incidence and patterns of newly developed pigmented lesions in adults at high risk for melanoma.
Br J Dermatol. 2024 Nov 26:ljae467. doi: 10.1093.
PubMed

LI CY, Wang WT, Ma SH, Lo LW, et al
Association of PCSK9 inhibitors with risk of nonmelanoma skin cancer: a retrospective cohort study.
Br J Dermatol. 2024 Nov 25:ljae438. doi: 10.1093.
PubMed Abstract available

AMAR Y, Niedermeier S, Silva R, Kublik S, et al
Skin microbiome dynamics in patients with polymorphic light eruption in response to UV radiations.
Br J Dermatol. 2024 Nov 22:ljae464. doi: 10.1093.
PubMed Abstract available

ZHANG B, Mei J, Liao Q, Zhou S, et al
Multitranscriptome analysis revealed that stromal cells in the papillary dermis promote angiogenesis in psoriasis vulgaris.
Br J Dermatol. 2024 Nov 21:ljae459. doi: 10.1093.
PubMed Abstract available

PHAN DB, Jourdain H, Descalzo-Gallego MA, Gonzalez-Quesada A, et al
Drug Survival and Safety of Biosimilars Compared with Originator Adalimumab for Psoriasis: A Multinational Cohort Study.
Br J Dermatol. 2024 Nov 20:ljae454. doi: 10.1093.
PubMed Abstract available

THOMPSON AR, Tziotzios C, Nesnas J, Randall R, et al
Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study.
Br J Dermatol. 2024;191:924-935.
PubMed Abstract available

XIONG X, Cesarato N, Gossmann Y, Wehner M, et al
A nonsense variant in KRT31 is associated with autosomal dominant monilethrix.
Br J Dermatol. 2024;191:979-987.
PubMed Abstract available

PATTINSON R, Trialonis-Suthakharan N, Pickles T, Austin J, et al
Measurement properties and interpretability of the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure.
Br J Dermatol. 2024;191:936-948.
PubMed Abstract available

OUYANG F, Yang H, Di Z, Hu J, et al
Life's Essential 8, genetic susceptibility and the risk of psoriatic disease: a prospective cohort study.
Br J Dermatol. 2024;191:897-905.
PubMed Abstract available

SINGH N, Schikowski T
Interactive effect of genetic and environmental risk factors on Psoriasis: current evidence and future directives.
Br J Dermatol. 2024 Nov 15:ljae450. doi: 10.1093.
PubMed

ZHENG DX, Jenkins RW
Real-world data confirms limited efficacy of dual anti-PD-1 and CTLA-4 immune checkpoint blockade in acral lentiginous melanoma.
Br J Dermatol. 2024 Nov 15:ljae445. doi: 10.1093.
PubMed

Correction to: COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma.
Br J Dermatol. 2024 Nov 11:ljae440. doi: 10.1093.
PubMed

VAN DER WEYDEN L, Del Castillo Velasco-Herrera M, Cheema S, Wong K, et al
Exploration of the mutational landscape of cutaneous leiomyoma confirms FH as a driver gene and identifies targeting purine metabolism as a potential therapeutic strategy.
Br J Dermatol. 2024 Nov 7:ljae432. doi: 10.1093.
PubMed

VAN VEEN FCAP, Rossel SVJ, Steijlen PM, Moser A, et al
The perceived quality of life in adult patients with inherited ichthyosis: a qualitative interview study.
Br J Dermatol. 2024 Nov 7:ljae436. doi: 10.1093.
PubMed

SHAH SFH, Arecco D, Draper H, Tiribelli S, et al
Ethical implications of artificial intelligence in skin cancer diagnostics: use-case analyses.
Br J Dermatol. 2024 Nov 6:ljae434. doi: 10.1093.
PubMed Abstract available

CHIU TM, Chen CB, Lu CW, Hui RC, et al
CCR8/CCL1 and CXCR3/CXCL10 axis mediated memory T cell activations in recalcitrant drug-induced hypersensitivity patients.
Br J Dermatol. 2024 Nov 6:ljae375. doi: 10.1093.
PubMed Abstract available

TAYLOR MA, Yuan M, Wang S, North JP, et al
A Case of Biologic-Resistant Hand Dermatitis Demonstrates Dual T2/T17 Transcriptomic Abnormalities and Responds to JAK Inhibition.
Br J Dermatol. 2024 Nov 5:ljae430. doi: 10.1093.
PubMed

SANGERS TE, van Doorn R
The usefulness of large language models for patient information on melanoma: challenges and opportunities.
Br J Dermatol. 2024 Nov 1:ljae429. doi: 10.1093.
PubMed

October 2024

WELLER RB, Gu J
Ultraviolet radiation is not the major cause of melanoma mortality in the UK and sun exposure advice should be revised.
Br J Dermatol. 2024 Oct 30:ljae426. doi: 10.1093.
PubMed

MAZEREEUW-HAUTIER J, Granier Tournier C, Hernandez-Martin A, Milesi S, et al
Biologics in congenital ichthyosis: are they effective?
Br J Dermatol. 2024 Oct 29:ljae420. doi: 10.1093.
PubMed Abstract available

RAUWERDINK DJW, Hoogland Y, Schrader AMR, Potjer TP, et al
Melanoma arising from pre-existing naevus in carriers of a germline CDKN2A pathogenic variant.
Br J Dermatol. 2024 Oct 29:ljae417. doi: 10.1093.
PubMed

CHEN M, Gao L
Carcinoid syndrome presenting as diffuse violaceous cutaneous flushing.
Br J Dermatol. 2024 Oct 26:ljae424. doi: 10.1093.
PubMed

BLAUVELT A, Papp K, Trivedi M, Barragan C, et al
Efficacy and safety of the ustekinumab biosimilar ABP 654 in patients with moderate-to-severe plaque psoriasis: a randomized, double-blinded, active-controlled, comparative clinical study over 52 weeks.
Br J Dermatol. 2024 Oct 23:ljae402. doi: 10.1093.
PubMed Abstract available

KATOH N, Tanaka A, Takahashi H, Shimizu R, et al
Long-term management of moderate-to-severe atopic dermatitis with lebrikizumab and concomitant topical corticosteroids: a 68-week, randomized, double-blind, placebo-controlled phase III trial in Japan (ADhere-J).
Br J Dermatol. 2024 Oct 23:ljae394. doi: 10.1093.
PubMed Abstract available

YANG X, Li L, Zhu M
Primary cutaneous Alternaria alstroemeriae infection.
Br J Dermatol. 2024 Oct 23:ljae409. doi: 10.1093.
PubMed

MCGILLIVRAY E, Ashouri K, Chatziioannou E, Gallegos JAO, et al
Combined PD-1 and CTLA-4 Blockade in an International Cohort of Patients with Acral Lentiginous Melanoma.
Br J Dermatol. 2024 Oct 23:ljae401. doi: 10.1093.
PubMed Abstract available

SILVERBERG JI, Bunick CG, Hong HC, Mendes-Bastos P, et al
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Week 16 results of an Open-label, Randomized, Efficacy Assessor-Blinded Head-to-Head Phase 3b/4 Study (Level Up).
Br J Dermatol. 2024 Oct 23:ljae404. doi: 10.1093.
PubMed Abstract available

ZHANG J, Ding Y, Wang P, Li L, et al
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan, and South Korea with moderate to severe plaque psoriasis: a phase 3 randomized clinical trial.
Br J Dermatol. 2024 Oct 22:ljae406. doi: 10.1093.
PubMed Abstract available

BLANCHARD G, Atallah I, Blanchard M, Fehrenbacher B, et al
Primary cutaneous T-cell lymphoma not otherwise specified (NOS) uncovering a novel RAB27A variant in Griscelli syndrome type 2.
Br J Dermatol. 2024 Oct 21:ljae412. doi: 10.1093.
PubMed

BARBIERI JS
Levelling up outcomes in atopic dermatitis through personalized dosing of upadacitinib.
Br J Dermatol. 2024 Oct 19:ljae410. doi: 10.1093.
PubMed

KOBYLETZKI LBV, Svensson A
Treatment for atopic dermatitis with JAK Inhibitors-useful recommendations from expert opinions.
Br J Dermatol. 2024 Oct 19:ljae396. doi: 10.1093.
PubMed

WANG Q, Niu G, Liu Z, Toma MA, et al
Circular RNA circASH1L(4,5) protects microRNA-129-5p from target-directed microRNA degradation in human skin wound healing.
Br J Dermatol. 2024 Oct 18:ljae405. doi: 10.1093.
PubMed Abstract available

CAMPBELL C, Mayatra JM, Neve AJ, Fletcher JM, et al
Inflammasomes: emerging therapeutic targets in hidradenitis suppurativa?
Br J Dermatol. 2024;191:670-679.
PubMed Abstract available

KORTE EWH, Baardman R, Pool G, Duipmans JC, et al
Navigating the diagnostic journey of epidermolysis bullosa: a qualitative study of the lived experiences and needs of parents and patients.
Br J Dermatol. 2024;191:737-745.
PubMed Abstract available

TSENG H, Stone C, Shulruf B, Murrell DF, et al
Establishing minimal clinically important differences for the Pemphigus Disease Area Index.
Br J Dermatol. 2024;191:823-831.
PubMed Abstract available

SORENSEN SBT, Farkas DK, Vestergaard C, Schmidt SAJ, et al
Urticaria and the risk of cancer: a Danish population-based cohort study.
Br J Dermatol. 2024;191:706-712.
PubMed Abstract available

YOSIPOVITCH G, Skayem C, Aroman MS, Taieb C, et al
International study on prevalence of itch: examining the role of itch as a major global public health problem.
Br J Dermatol. 2024;191:713-718.
PubMed Abstract available

RUTKOWSKI D, Scholey R, Davies J, Pye D, et al
Epidermal growth factor receptor/mitogen-activated kinase inhibitor treatment induces a distinct inflammatory hair follicle response that includes collapse of immune privilege.
Br J Dermatol. 2024;191:791-804.
PubMed Abstract available

BETTUZZI T, Welfringer-Morin A, Ingen-Housz-Oro S, Bataille P, et al
Comparison of incidence, causes and prognosis of adult and paediatric epidermal necrolysis: a French population-based study.
Br J Dermatol. 2024;191:698-705.
PubMed Abstract available

XIONG Y, Xia Y, Zhang X, Jiang B, et al
Joint exposure to multiple air pollutants, genetic risk, and incident psoriasis: a large-scale prospective cohort study.
Br J Dermatol. 2024 Oct 12:ljae391. doi: 10.1093.
PubMed Abstract available

KUMARI R, Apfelbacher CJ, Nelson-Piercy C, Flohr C, et al
The management of atopic dermatitis in women of childbearing age: confused terminology, lack of evidence and resulting clinical inertia.
Br J Dermatol. 2024 Oct 12:ljae398. doi: 10.1093.
PubMed

LAI C, Fuggle NR, Matin RN, Tanaka RJ, et al
Artificial Intelligence and Machine Learning in Dermatological Research and Healthcare: British Society for Investigative Dermatology Skin Club Report - Southampton April 2024.
Br J Dermatol. 2024 Oct 12:ljae395. doi: 10.1093.
PubMed

VAN DER WEYDEN L, Del Castillo Velasco-Herrera M, Cheema S, Wong K, et al
Comprehensive mutational profiling identifies new driver events in cutaneous leiomyosarcoma.
Br J Dermatol. 2024 Oct 11:ljae386. doi: 10.1093.
PubMed Abstract available

Correction to: Single-cell RNA sequencing comparison of CD4+, CD8+ and T-cell receptor gammadelta+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes.
Br J Dermatol. 2024 Oct 11:ljae374. doi: 10.1093.
PubMed

EJEZIE CL, Ayieko S, Anunobi P, Oladoyin J, et al
Skin Bleaching: A Socio-ecological Perspective.
Br J Dermatol. 2024 Oct 9:ljae368. doi: 10.1093.
PubMed

BLAUVELT A, Reckleff J, Zhao Y, Clark M, et al
Content Evaluation of Pruritus, Skin Pain, and Sleep Disturbance Patient-Reported Outcome Measures in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: Qualitative Interviews.
Br J Dermatol. 2024 Oct 4:ljae346. doi: 10.1093.
PubMed Abstract available

KAMMINGA NC, Kievits JE, Plaisier PW, Burgers JS, et al
Do Large Language Model Chatbots perform better than established patient information resources in answering patient questions? A comparative study on melanoma.
Br J Dermatol. 2024 Oct 4:ljae377. doi: 10.1093.
PubMed Abstract available

ROMANI J, Roses C, Brillet F, Fernandez-Vela J, et al
Microbiome characterization of skin biopsies in Spanish patients with hidradenitis suppurativa shows a decrease in D1 and H1 lineages of Cutibacterium acnes.
Br J Dermatol. 2024 Oct 1:ljae371. doi: 10.1093.
PubMed

PANDEYA N, Olsen CM, Neale RE, Whiteman DC, et al
Melanoma as a detection-dependent cancer: proxy measures of screening and surveillance associated with 3-year incidence of detection procedures for skin cancer in a national prospective study.
Br J Dermatol. 2024 Oct 1:ljae372. doi: 10.1093.
PubMed Abstract available

September 2024

LAI CC, Shao SC, Tsai ET, Chi CC, et al
Efficacy and safety of biologics and small molecule inhibitors in treating genital psoriasis: A systematic review of randomised controlled trials.
Br J Dermatol. 2024 Sep 30:ljae370. doi: 10.1093.
PubMed

SOUTH AP
Stopping a runaway train: targeting fibrosis in recessive dystrophic epidermolysis bullosa.
Br J Dermatol. 2024;191:482-483.
PubMed

CHEN ML, Kim J, Naik HB, Aleshin MA, et al
Analysing common topics of secure patient messages in hidradenitis suppurativa: a text-embedding and natural language-processing approach.
Br J Dermatol. 2024;191:633-635.
PubMed

CARRASCOSA JM, Munera-Campos M
Prurigo nodularis: the difference between knowing the path and walking the path.
Br J Dermatol. 2024;191:480-481.
PubMed

KIM J, Kim JH
Clinical relevance of circulating autoantigen-specific T-follicular regulatory cells in pemphigus vulgaris.
Br J Dermatol. 2024;191:485-486.
PubMed

BERTOLD C, Delaunay P, Cathelineau AC, Chassang M, et al
Efficacy of hypnotherapy in chronic idiopathic pruritus: a single-arm prospective pilot study.
Br J Dermatol. 2024;191:644-645.
PubMed

AMBER KT, Feldman RJ
The safety of topical vs. oral steroids in bullous pemphigoid: considerations for retrospective analyses.
Br J Dermatol. 2024;191:479-480.
PubMed

HEBERT V, Novarino J, Maho-Vaillant M, Perals C, et al
The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgaris.
Br J Dermatol. 2024;191:605-615.
PubMed Abstract available

BAHLOUL D, Hudson R, Balogh O, Mathias E, et al
Prevalence, incidence and treatment patterns of prurigo nodularis in England: a retrospective database analysis.
Br J Dermatol. 2024;191:548-555.
PubMed Abstract available

BESSIS D, Poujade L, Cossee M, Boursier G, et al
Mosaic EGFR exon 20 in-frame insertion pathogenic variants are associated with papular epidermal naevus with 'skyline' basal cell layer (PENS).
Br J Dermatol. 2024;191:641-644.
PubMed

HUBENTHAL M, Dai C, Brown SJ, Heinrich L, et al
Mapping SCORing of Atopic Dermatitis (SCORAD) and objective SCORAD to the Eczema Area and Severity Index to facilitate large-scale meta-analyses of molecular data.
Br J Dermatol. 2024;191:637-639.
PubMed

PRIMERANO A, De Domenico E, Cianfarani F, De Luca N, et al
Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa.
Br J Dermatol. 2024;191:568-579.
PubMed Abstract available

JOHNS JR, Vyas J, Ali FM, Ingram JR, et al
The Dermatology Life Quality Index as the primary outcome in randomized clinical trials: a systematic review.
Br J Dermatol. 2024;191:497-507.
PubMed Abstract available

GARATE D, Thang CJ, Schmidt M, Ravanassa S, et al
Granuloma annulare and the risk of autoimmune conditions: a multicentre retrospective cohort analysis.
Br J Dermatol. 2024;191:626-627.
PubMed

KRIDIN K, Bieber K, Vorobyev A, Moderegger EL, et al
Risk of death, major adverse cardiac events and relapse in patients with bullous pemphigoid treated with systemic or topical corticosteroids.
Br J Dermatol. 2024;191:539-547.
PubMed Abstract available

LYONS D, Louly Nathan A, Pender E, Murray G, et al
Semaglutide for weight loss in people with obesity as an adjunctive treatment for hidradenitis suppurativa: its impact on disease control and quality of life.
Br J Dermatol. 2024;191:631-633.
PubMed

LONG A, O'Malley S, Collins S
The sunbed trend in Ireland.
Br J Dermatol. 2024;191:630-631.
PubMed

ALAVI A, Prens EP, Kimball AB, Frew JW, et al
Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial.
Br J Dermatol. 2024;191:508-518.
PubMed Abstract available

CARR DF, Hanson A
Stevens-Johnson syndrome/toxic epidermal necrolysis: international consensus, advances and opportunities.
Br J Dermatol. 2024 Sep 16:ljae358. doi: 10.1093.
PubMed

TENSEN CP, Vermeer MH
Single cell analyses of cutaneous T-cell lymphoma biopsies.
Br J Dermatol. 2024 Sep 13:ljae351. doi: 10.1093.
PubMed

GALENTINE E, Powers CM, McAleer L, Rivera S, et al
Hidden hurts: life with lichen sclerosus - a patient perspective.
Br J Dermatol. 2024 Sep 12:ljae357. doi: 10.1093.
PubMed

STEVENS HP, Pampena R, Farnetani F, Pellicani G, et al
The use of Reflectance Confocal Microscopy to diagnose Basal Cell Carcinoma in the United Kingdom: A Prospective Observational Trial at a Single Centre.
Br J Dermatol. 2024 Sep 11:ljae356. doi: 10.1093.
PubMed Abstract available

STEVENS HP, Pellacani G, Angus C, El-Jabbour JN, et al
The use of Reflectance Confocal Microscopy to diagnose Malignant Melanoma and Lentigo Maligna in the United Kingdom: A Prospective Observational Trial at a Single Centre.
Br J Dermatol. 2024 Sep 10:ljae354. doi: 10.1093.
PubMed Abstract available

HAAG C, Alexis A, Aoki V, Bissonnette R, et al
A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council.
Br J Dermatol. 2024 Sep 10:ljae342. doi: 10.1093.
PubMed Abstract available

MAHUMUD RA
The emerging burden of melanoma overdiagnosis in Australia: Who bears the cost-patients or the healthcare system?
Br J Dermatol. 2024 Sep 9:ljae339. doi: 10.1093.
PubMed

POSADA V, Toland AE
Role of albinism and pigment-related genes in amelanotic melanoma formation.
Br J Dermatol. 2024 Sep 9:ljae353. doi: 10.1093.
PubMed

SIMPSON C, Leducq S, Venables Z, Yiu ZZN, et al
The association between prescribed oral anti-diabetic medication for type 2 diabetes mellitus and skin cancer risk: a systematic review and meta-analysis.
Br J Dermatol. 2024 Sep 6:ljae341. doi: 10.1093.
PubMed

ARDERN-JONES MR, Brown SJ, Flohr C, Hossain P, et al
An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024.
Br J Dermatol. 2024 Sep 5:ljae344. doi: 10.1093.
PubMed Abstract available

GELLER AC, Stratigos AJ
Exploring sex and site- specific differences in melanoma.
Br J Dermatol. 2024 Sep 4:ljae345. doi: 10.1093.
PubMed

August 2024

YAMAZAKI E, Fujimura T, Takahashi-Watanabe M, Tada S, et al
Decreased serum levels of IL-4 correlate with the efficacy of the PAI-1 inhibitor TM5614 in patients with malignant melanoma refractory to anti-PD-1 antibodies: post hoc study of TM5614-MM trial.
Br J Dermatol. 2024 Aug 31:ljae343. doi: 10.1093.
PubMed

WEI L, Fitzgerald ME, Yan L, Murakami M, et al
Photodynamic therapy reduces the burden of small ultraviolet-induced epidermal clones in human and mouse skin.
Br J Dermatol. 2024 Aug 27:ljae314. doi: 10.1093.
PubMed

AHMED A, Mohandas P, Taylor R, Assalman I, et al
'Psycholag': a new term to describe the delay between physical and psychological improvement in patients with skin disease.
Br J Dermatol. 2024 Aug 22:ljae333. doi: 10.1093.
PubMed

GIPPLE MO, Dhami RK, Latour E, Keller JJ, et al
Morgellons disease shows a lower quality of life than psoriasis, atopic dermatitis, and prurigo nodularis.
Br J Dermatol. 2024 Aug 21:ljae335. doi: 10.1093.
PubMed

STURM RA, Smit DJ, Duffy DL, McLean C, et al
Uncovering molecular mechanisms for amelanotic/hypopigmented primary cutaneous melanoma.
Br J Dermatol. 2024 Aug 21:ljae336. doi: 10.1093.
PubMed Abstract available

SERVATTALAB SE, Lee M, Hlobik M, Song H, et al
Examining racial and ethnic disparities in diagnosis and access to care in infantile atopic dermatitis in the United States: a retrospective cohort study.
Br J Dermatol. 2024 Aug 20:ljae322. doi: 10.1093.
PubMed Abstract available

O'REILLY P, Walsh S, Bunker CB, Ryan S, et al
The quality-of-life impact of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) on patients' lives: An interpretative descriptive qualitative study.
Br J Dermatol. 2024 Aug 20:ljae334. doi: 10.1093.
PubMed Abstract available

KPENOU FC, Paul C, Seneschal J, Andreu N, et al
The Atopic Dermatitis Patient Journey: Insights from a Qualitative Study.
Br J Dermatol. 2024 Aug 18:ljae329. doi: 10.1093.
PubMed

CHIESA FUXENCH ZC, Mitra N, Grice E, Hoffstad O, et al
Is seborrhoeic dermatitis of infancy and childhood related to maternal history of seborrhoeic dermatitis? A large population-based cohort study from the UK.
Br J Dermatol. 2024 Aug 18:ljae331. doi: 10.1093.
PubMed Abstract available

KORTE EWH, Pasmooij AMG, Bolling MC, Hickey S, et al
Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa.
Br J Dermatol. 2024;191:463-465.
PubMed

OH BH, Kim KH
Applying a novel optical technique for residual cancer detection with accuracy evaluation: a cornerstone for field implementation.
Br J Dermatol. 2024;191:322-323.
PubMed

EHIZOGIE E, Maghari I, Lo S, Albrecht J, et al
Hidradenitis suppurativa, systemic inflammatory response syndrome and sepsis: a database study.
Br J Dermatol. 2024;191:451-453.
PubMed

CURMAN P, Jebril W, Larsson H, Bachar-Wikstrom E, et al
Increased risk of depression and anxiety in individuals with Darier disease.
Br J Dermatol. 2024;191:462-463.
PubMed

YIU D, Aguilar-Duran S, Edwards C, Chauhan D, et al
Increased incidence of co-trimoxazole-induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors.
Br J Dermatol. 2024;191:465-467.
PubMed

DALE C, Hewitt RM, Purcell C, Pandya N, et al
'Feeling like a second-class citizen': exploring the impact, self-management and existing support for adults living with acne and/or post-inflammatory hyperpigmentation and scarring.
Br J Dermatol. 2024;191:469-470.
PubMed

HAS C
MiTES: itch or pain?
Br J Dermatol. 2024;191:323-324.
PubMed

RHODES LE
Vitamin D status in patients with erythropoietic protoporphyria taking the systemic photoprotective agent afamelanotide.
Br J Dermatol. 2024;191:317-318.
PubMed

STADLER R
The interferon story continues: EORTC CLTG study explores pegylated interferon alpha-2a's role in treating mycosis fungoides/Sezary syndrome.
Br J Dermatol. 2024;191:321-322.
PubMed

DEKKERS C, de Bruin-Weller M
The pleiotropic role of interleukin-13 in the pathogenesis of atopic dermatitis.
Br J Dermatol. 2024;191:316-317.
PubMed

MAGHARI I, Abiad H, Griffin T, Albrecht J, et al
Hidradenitis suppurativa (HS), systemic inflammatory response syndrome and sepsis, sepsis caused by HS: an empty systematic review.
Br J Dermatol. 2024;191:449-450.
PubMed

KLUIJVER LG, Nekouei Shahraki M, Wagenmakers MAEM, Hanssen BE, et al
The effects of cholecalciferol and afamelanotide on vitamin D levels in erythropoietic protoporphyria: a multicentre cohort study.
Br J Dermatol. 2024;191:357-364.
PubMed Abstract available

MITSUNAGA K, Bagot M, Ram-Wolff C, Guenova E, et al
Real-world study of pegylated interferon alpha-2a to treat mycosis fungoides/Sezary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study.
Br J Dermatol. 2024;191:419-427.
PubMed Abstract available

COHN E, Palma G, Mastacouris N, Strunk A, et al
Incidence of anxiety disorder in adults with hidradenitis suppurativa.
Br J Dermatol. 2024;191:351-356.
PubMed Abstract available

NOCHAIWONG S, Ruengorn C, Thavorn K, Noppakun K, et al
Psychometric evaluation of the multidimensional Uraemic Pruritus in Dialysis patients (UP-Dial) scale: comparison of haemodialysis and peritoneal dialysis patients with chronic pruritus.
Br J Dermatol. 2024;191:375-384.
PubMed Abstract available

SIBBALD C, Castelo-Soccio L
Review of global epidemiology data for alopecia areata highlights gaps and a call for action.
Br J Dermatol. 2024;191:315-316.
PubMed

JEON JJ, Jung SW, Kim YH, Parisi R, et al
Global, regional and national epidemiology of alopecia areata: a systematic review and modelling study.
Br J Dermatol. 2024;191:325-335.
PubMed Abstract available

BANERJEE A, Ezzedine K, Shore R, Peeva E, et al
An analysis of inter- and intra-rater Facial Vitiligo Area Scoring Index assessments in adults with active nonsegmental vitiligo.
Br J Dermatol. 2024;191:453-454.
PubMed

HAMA N, Aoki S, Chen CB, Hasegawa A, et al
Recent progress of Stevens-Johnson syndrome/toxic epidermal necrolysis: Diagnosis criteria, pathogenesis and therapy.
Br J Dermatol. 2024 Aug 14:ljae321. doi: 10.1093.
PubMed Abstract available

CHENNAREDDY S, Rindler K, Ruggiero JR, Alkon N, et al
Single-cell RNA sequencing comparison of CD4+, CD8+ and TCR-gammadelta+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes.
Br J Dermatol. 2024 Aug 12:ljae313. doi: 10.1093.
PubMed Abstract available

KIM SR, Choi YG, Jo SJ
Duration of smoking cessation for the prevention of psoriasis vulgaris and palmoplantar pustulosis.
Br J Dermatol. 2024 Aug 6:ljae317. doi: 10.1093.
PubMed

FANG Y, Qi J, Jiang Y, Lin Z, et al
Fish oil supplementation protects skin from yellowness induced by fine particulate matter through anti-inflammatory mechanism: a randomized, double-blind, placebo-controlled clinical trial.
Br J Dermatol. 2024 Aug 5:ljae311. doi: 10.1093.
PubMed

July 2024

RAYMUNDO C, Cella D, Wagner L, Hippe DS, et al
Development and psychometric properties of the Functional Assessment of Cancer Therapy-Cutaneous T-Cell Lymphoma (FACT-CTCL).
Br J Dermatol. 2024 Jul 30:ljae308. doi: 10.1093.
PubMed Abstract available

WILLEMZE R
Primary cutaneous acral CD8+ T-cell lymphoproliferative disorder: a benign or malignant process?
Br J Dermatol. 2024 Jul 26:ljae303. doi: 10.1093.
PubMed

DE BRITO M, O'Toole EA
Exploring the role of cytokeratin-17 in skin tumourigenesis and HPV persistence.
Br J Dermatol. 2024 Jul 25:ljae294. doi: 10.1093.
PubMed

ALEXANDER H, Malek R, Prieto-Merino D, Gribaleva E, et al
A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR register.
Br J Dermatol. 2024 Jul 24:ljae287. doi: 10.1093.
PubMed Abstract available

VAN DOORN R
Supplemental vitamin D on trial: no evidence of benefit as an adjuvant treatment for melanoma.
Br J Dermatol. 2024 Jul 23:ljae302. doi: 10.1093.
PubMed

LINDSAY D, Bell KJL, Olsen CM, Whiteman DC, et al
Estimating the magnitude and healthcare costs of melanoma in situ and thin invasive melanoma overdiagnosis in Australia.
Br J Dermatol. 2024 Jul 19:ljae296. doi: 10.1093.
PubMed Abstract available

OLSEN CM, Pandeya N, Neale RE, Law MH, et al
Phenotypic and genotypic risk factors for invasive melanoma by sex and body site.
Br J Dermatol. 2024 Jul 19:ljae297. doi: 10.1093.
PubMed Abstract available

HARRISON SR, Campbell F, Bennett H, De Marco G, et al
High prevalence of undiagnosed and undertreated psoriasis in a UK urban population: results from the observational COPPACA study.
Br J Dermatol. 2024 Jul 19:ljae292. doi: 10.1093.
PubMed

RENTROIA-PACHECO B, Shain AH
Cutaneous squamous cell carcinoma progression: what does a meta-analysis of transcriptomic studies tell us?
Br J Dermatol. 2024 Jul 17:ljae293. doi: 10.1093.
PubMed

MACAULAY ARK, Yang J, Price MA, Forster CL, et al
Chondroitin sulfate proteoglycan 4 (CSPG4) increases invasion of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma by modifying TGFbeta signaling.
Br J Dermatol. 2024 Jul 17:ljae295. doi: 10.1093.
PubMed Abstract available

Correction to: Prevalence, incidence, mortality and healthcare resource use for generalized pustular psoriasis, palmoplantar pustulosis and plaque psoriasis in England: a population-based cohort study.
Br J Dermatol. 2024 Jul 17:ljae285. doi: 10.1093.
PubMed

New British Skin Foundation/Skin Health Alliance Psychodermatology Research Award now available.
Br J Dermatol. 2024;191:309.
PubMed

BATTISTELLA M
Paediatric lymphomatoid papulosis: a benign clonal T-cell disorder that is a harbinger of haematological malignancy.
Br J Dermatol. 2024;191:158-159.
PubMed

DOOLAN BJ, Thomas BR
Bursting the bubble on diagnostics: artificial intelligence in autoimmune bullous disease.
Br J Dermatol. 2024;191:160-161.
PubMed

ANDRADE LF, Haq Z, Abdi P, Diaz MJ, et al
Impact of pruritus on patient fatigue: a cross-sectional study.
Br J Dermatol. 2024;191:292-293.
PubMed

REICH A
Nemolizumab: a new key player in the treatment of prurigo nodularis.
Br J Dermatol. 2024;191:154-155.
PubMed

THEIN D, Maul JT, Schmid-Grendelmeier P, Thyssen JP, et al
Prevalence of ichthyoses in Denmark: a nationwide registry-based study.
Br J Dermatol. 2024;191:305-306.
PubMed

SAMUELOV L
Dystrophic epidermolysis bullosa: from disease biology to biologic therapy.
Br J Dermatol. 2024;191:159-160.
PubMed

GAMBICHLER T, Razeghpour F, Sorescu E, Stucker M, et al
High intratumoral 5-hydroxymethylcytosine levels protect against disease relapse in patients with atypical fibroxanthoma and pleomorphic dermal sarcoma.
Br J Dermatol. 2024;191:295-296.
PubMed

GUPTA V, Taneja N, Sati HC, Sreenivas V, et al
'Substantial clinical benefit' and 'substantial clinical worsening' cutoff of Vitiligo Impact Scale (VIS)-22 change scores.
Br J Dermatol. 2024;191:307-308.
PubMed

GRATTAN CEH, Kocaturk E
How relevant are eosinophils to chronic spontaneous urticaria? No evidence of clinical benefit from eosinophil depletion with benralizumab.
Br J Dermatol. 2024;191:153-154.
PubMed

SARKOVICS K, Kolodney JA, Kolodney MS
Programmed death receptor-1 and programmed death ligand-1 checkpoint inhibition-associated bullous pemphigoid: a propensity-matched retrospective cohort study.
Br J Dermatol. 2024;191:299-300.
PubMed

YOKOZEKI H, Murota H, Matsumura T, Komazaki H, et al
Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged >/= 13 years.
Br J Dermatol. 2024;191:200-208.
PubMed Abstract available

BRAZZELLI V, Michelerio A
Use of a large patient database to analyse disease burden and treatment patterns among patients with vitiligo.
Br J Dermatol. 2024;191:156-157.
PubMed

MCCARTHY RL, Schwartz J, Oldham J, Bodemer C, et al
A cross-sectional study of erythromelalgia in patients with pachyonychia congenita.
Br J Dermatol. 2024;191:300-302.
PubMed

CAPURRO N, Pastore VP, Touijer L, Odone F, et al
A deep learning approach to direct immunofluorescence pattern recognition in autoimmune bullous diseases.
Br J Dermatol. 2024;191:261-266.
PubMed Abstract available

ELEFTHERIADOU V, Delattre C, Chetty-Mhlanga S, Lee C, et al
Burden of disease and treatment patterns in patients with vitiligo: findings from a national longitudinal retrospective study in the UK.
Br J Dermatol. 2024;191:216-224.
PubMed Abstract available

LAIMER M
Nonsense variant readthrough therapy for epidermolysis bullosa.
Br J Dermatol. 2024;191:161-162.
PubMed

CAMPBELL F, Laws P
Managing risk of liver fibrosis in patients with psoriasis being considered for methotrexate.
Br J Dermatol. 2024;191:163.
PubMed

ALTRICHTER S, Gimenez-Arnau AM, Bernstein JA, Metz M, et al
Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial.
Br J Dermatol. 2024;191:187-199.
PubMed Abstract available

WOODLEY DT, Hao M, Kwong A, Levian B, et al
Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial.
Br J Dermatol. 2024;191:267-274.
PubMed Abstract available

HOWELLS L
Patient-Reported Impact of Dermatological Diseases (PRIDD) is a new patient-reported outcome measure for dermatology: why is it needed?
Br J Dermatol. 2024;191:e4.
PubMed

XU Y, Guo L, Wu S, Zhang T, et al
Causal effect of elevated body mass index on hidradenitis suppurativa: a two-sample Mendelian randomization study.
Br J Dermatol. 2024;191:290-292.
PubMed

HUANG Y, Pu W, Wang L, Ma Q, et al
ACKR1+ Endothelial Cells Mediate Leukocyte Infiltration and Synergize with SFRP2/ASPN+ Fibroblasts to Promote Skin Fibrosis in Systemic Sclerosis.
Br J Dermatol. 2024 Jul 15:ljae286. doi: 10.1093.
PubMed Abstract available

BRUCE G, Rosala-Hallas A, Jones AP, Turner C, et al
The effects of ciclosporin and methotrexate on kidney function in the treatment of severe atopic dermatitis in children - results from the TREAT trial.
Br J Dermatol. 2024 Jul 15:ljae276. doi: 10.1093.
PubMed

WANG H, Wu Y, Bassetti JA, Wang Z, et al
A gain-of-function variant in SREBF1 causes generalized skin hyperpigmentation with congenital cataracts.
Br J Dermatol. 2024 Jul 15:ljae291. doi: 10.1093.
PubMed Abstract available

LI A, Musters AH, Hyseni A, Gerbens LAA, et al
Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-center cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.
Br J Dermatol. 2024 Jul 15:ljae289. doi: 10.1093.
PubMed

LALLAS K, Spyridonos P, Kittler H, Tschandl P, et al
Prediction of melanoma metastasis using dermatoscopy deep features. An international multicenter cohort study.
Br J Dermatol. 2024 Jul 12:ljae281. doi: 10.1093.
PubMed

DAVITI M, Papadimitriou I, Cinotti E, Lallas A, et al
Atypical melanocytes of an Atypical Spitz Tumor observed with Optical Super-High Magnification Dermoscopy.
Br J Dermatol. 2024 Jul 2:ljae277. doi: 10.1093.
PubMed

JIA Q, Cao Q, Peng C, Shui X, et al
Predictive features for effectiveness of dupilumab in elderly patients with atopic dermatitis: a real-world study.
Br J Dermatol. 2024 Jul 2:ljae278. doi: 10.1093.
PubMed

KLEEMANN J, Schilling B
Multicenter phase II trial of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab in japanese advanced melanoma patients: Immune resistance remains one of the major efforts in melanoma research.
Br J Dermatol. 2024 Jul 2:ljae279. doi: 10.1093.
PubMed

June 2024

SCHIELEIN L, Ziehfreund S, Biedermann T, Zink A, et al
"When you do not feel comfortable in your skin, you cannot get out of it" - A Qualitative Interview Study exploring Psychosocial Impact and Coping Strategies among Patients with Prurigo Nodularis.
Br J Dermatol. 2024 Jun 28:ljae274. doi: 10.1093.
PubMed

WOBSE M, Appenzeller S, Roth S, Siedel C, et al
Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder.
Br J Dermatol. 2024 Jun 27:ljae256. doi: 10.1093.
PubMed Abstract available

HAGENSTROM K, Klinger T, Muller K, Willers C, et al
Utilization and related harms of systemic glucocorticosteroids for atopic dermatitis: claims data analysis.
Br J Dermatol. 2024 Jun 27:ljae250. doi: 10.1093.
PubMed Abstract available

VON KOBYLETZKI LB, Svensson A
Generalised pustular psoriasis, palmoplantar pustulosis, and plaque psoriasis have different survival rates and health care needs.
Br J Dermatol. 2024 Jun 25:ljae271. doi: 10.1093.
PubMed

ESPOSITO M, Yerly L, Shukla P, Hermes V, et al
COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma.
Br J Dermatol. 2024 Jun 25:ljae258. doi: 10.1093.
PubMed Abstract available

DE SMEDT J, Van Kelst S, Janssen L, Marasigan V, et al
High dose vitamin D supplementation does not improve outcome in a cutaneous melanoma population: results of a randomized double-blind, placebo-controlled study (ViDMe trial).
Br J Dermatol. 2024 Jun 24:ljae257. doi: 10.1093.
PubMed Abstract available

Long-term response to treatment with guselkumab in people with moderate-to-severe psoriasis.
Br J Dermatol. 2024;191:e3.
PubMed

TZOUMPA S, Ingen-Housz-Oro S, de Masson A, Pham-Ledard A, et al
Evolution of patients with Sezary syndrome after mogamulizumab discontinuation for any cause except progression: a multicentre retrospective study (Moga-stop Study).
Br J Dermatol. 2024;191:143-144.
PubMed

XIE W, Kong X, Liu W, Liang G, et al
Antifungal-resistant Trichophyton indotineae: transmission warrants priority attention and international collaboration.
Br J Dermatol. 2024;191:146-147.
PubMed

HORISSIAN M, Samaan C, Cohrs A, Kirby J, et al
Trends in antibiotic prescriptions for hidradenitis suppurativa from 2015 to 2021.
Br J Dermatol. 2024;191:142-143.
PubMed

ABDOLRASOULI A, Hay RJ
Antifungal-resistant Trichophyton indotineae: transmission is occurring outside previously identified endemic areas - are we prepared?
Br J Dermatol. 2024;191:145-146.
PubMed

DANBY SG
Debunking the myth that all emollients are equal opens the door for future atopic dermatitis prevention studies.
Br J Dermatol. 2024;191:6-7.
PubMed

TULL TJ, Benton EC, Semkova K, Watson NA, et al
Combined rituximab and belimumab to treat recalcitrant epidermolysis bullosa aquisita associated with systemic lupus erythematosus.
Br J Dermatol. 2024;191:138-140.
PubMed

GOLETZ S, Probst C, Komorowski L, Radzimski C, et al
Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin beta4 subunit.
Br J Dermatol. 2024;191:140-141.
PubMed

LIU Y, Liu J, Chen Y, Mo R, et al
Potential digenic inheritance of SERPINB7 and SERPINA12 variants in Chinese patients with Nagashima-type palmoplantar keratosis.
Br J Dermatol. 2024;191:136-138.
PubMed

LIANG L, Peng S, Huang S, Wang H, et al
Progressive hyperpigmentation and lentigines due to KIT variants improving with imatinib.
Br J Dermatol. 2024;191:148-149.
PubMed

KEARNEY N, Kirby B
Prior exposure to fumaric acid esters does not impact on subsequent treatment response to guselkumab.
Br J Dermatol. 2024;191:5-6.
PubMed

SALAMON G, Strobl S, Field-Werners U, Diem A, et al
Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure.
Br J Dermatol. 2024;191:75-81.
PubMed Abstract available

THACI D, Pinter A, Sebastian M, Termeer C, et al
Guselkumab demonstrates long-term efficacy and maintenance of treatment response postwithdrawal in systemic treatment-naive patients and nonresponders to fumaric acid esters: results from parts II and III of a randomized active-comparator-controlled p
Br J Dermatol. 2024;191:36-48.
PubMed Abstract available

HASCHE D, Hufbauer M, Braspenning-Wesch I, Stephan S, et al
Cytokeratin-17 expression is commonly observed in keratinocytic skin tumours and controls tissue homeostasis impacting HPV protein expression.
Br J Dermatol. 2024 Jun 15:ljae255. doi: 10.1093.
PubMed Abstract available

MCMAHON M, Deacon DC
Spatial sequencing reveals transcriptional variation between amelanotic and pigmented acral melanoma.
Br J Dermatol. 2024 Jun 15:ljae253. doi: 10.1093.
PubMed

FISCHER G
The impact of vulval lichen sclerosus in young people: a call for better awareness, individualised maintenance plans and revised guidelines.
Br J Dermatol. 2024 Jun 15:ljae254. doi: 10.1093.
PubMed

BENCOMO T, Lee CS
Gene expression landscape of cutaneous squamous cell carcinoma progression.
Br J Dermatol. 2024 Jun 13:ljae249. doi: 10.1093.
PubMed Abstract available

BARBAROT S, Aubert H, Vibet MA, Leray M, et al
Effectiveness of a nurse-led one-to-one education programme in addition to standard care in children with atopic dermatitis: a multicentre randomized control trial.
Br J Dermatol. 2024 Jun 12:ljae111. doi: 10.1093.
PubMed Abstract available

FISCHER J
Confetti Cure: Reversing the Genetic Kaleidoscope of Ichthyosis.
Br J Dermatol. 2024 Jun 11:ljae248. doi: 10.1093.
PubMed

MITRA R, Fitzsimmons H, Hale T, Tan ST, et al
Recent Advances in Understanding the Molecular Basis of Infantile Haemangioma Development.
Br J Dermatol. 2024 Jun 7:ljae241. doi: 10.1093.
PubMed Abstract available

VENABLES ZC, Wakkee M
Basal cell carcinoma incidence trends - can we stop the surge?
Br J Dermatol. 2024 Jun 5:ljae239. doi: 10.1093.
PubMed

LOUVEAU B, Nakouri I, Jouenne F, Baroudjian B, et al
Genomic profiling of a skin adnexal carcinomas cohort using a comprehensive high throughput sequencing approach.
Br J Dermatol. 2024 Jun 5:ljae233. doi: 10.1093.
PubMed

GUTTMAN-YASSKY E, Croft M, Geng B, Rynkiewicz N, et al
The role of OX40L/OX40 axis signalling in atopic dermatitis.
Br J Dermatol. 2024 Jun 5:ljae230. doi: 10.1093.
PubMed Abstract available

FUJIMURA T, Yoshino K, Kato H, Fukushima S, et al
Phase II, multicenter study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-PD-1 antibody-refractory malignant melanoma: TM5614-MM trial.
Br J Dermatol. 2024 Jun 4:ljae231. doi: 10.1093.
PubMed Abstract available

May 2024

KISS O, Bahri R, Watson REB, Chike C, et al
The impact of irritant challenge on the skin barrier and myeloid resident immune cells in post-menopausal women is modulated by hormone replacement therapy.
Br J Dermatol. 2024 May 31:ljae226. doi: 10.1093.
PubMed Abstract available

CHOI ME, Choi EJ, Lee JH, Won CH, et al
Spatial transcriptome analysis of amelanotic acral melanoma reveals distant molecular determinants compared to pigmented acral melanoma.
Br J Dermatol. 2024 May 30:ljae224. doi: 10.1093.
PubMed Abstract available

SHEN CH, Yang YS, Lee IT, Chiang MH, et al
Sodium-glucose cotransporter protein-2 inhibitors for diabetes and the reduced risk of inflammatory skin diseases.
Br J Dermatol. 2024 May 29:ljae229. doi: 10.1093.
PubMed

BARBIERI A, Orloff J, Gulati N, Brown RM, et al
Living in my own skin: dermatological concerns and gender-affirming care as a trans person with neurofibromatosis type 1.
Br J Dermatol. 2024 May 27:ljae170. doi: 10.1093.
PubMed

VAHER H
Expanding the knowledge about the TNF-alpha induced GSDME-mediated pyroptosis in psoriasis.
Br J Dermatol. 2024 May 23:ljae223. doi: 10.1093.
PubMed

LUO L, Cheng H, Liu Z, Olszewski P, et al
Single-cell transcriptomic analysis identifies infiltrating plasmacytoid dendritic cells in psoriasis epidermis.
Br J Dermatol. 2024 May 22:ljae210. doi: 10.1093.
PubMed

Correction to: Loss-of-function variants in GLMN are associated with generalized skin hyperpigmentation with or without glomuvenous malformation.
Br J Dermatol. 2024 May 22:ljae212. doi: 10.1093.
PubMed

FRYSZ M, Patel S, Li MOY, Griffiths CEM, et al
Prevalence, incidence, mortality, and healthcare resource use for generalised pustular psoriasis, palmoplantar pustulosis, and plaque psoriasis in England: a population-based cohort study.
Br J Dermatol. 2024 May 22:ljae217. doi: 10.1093.
PubMed Abstract available

HANRAHAN GB, Tsibris HC
Mutational Landscape and Tumor Mutational Burden in Adult Patients with Malignant Melanoma Arising From Congenital Nevi.
Br J Dermatol. 2024 May 21:ljae214. doi: 10.1093.
PubMed

MORREL B, Kampherbeek JHJ, Ten Kate-Booij MJ, van der Avoort IAM, et al
Growing up with juvenile vulvar lichen sclerosus, the experiences and care needs of adult women with lichen sclerosus since childhood: a qualitative exploration.
Br J Dermatol. 2024 May 21:ljae203. doi: 10.1093.
PubMed Abstract available

Correction to: Breastfeeding decreases the risk of developing psoriasis through to early adulthood.
Br J Dermatol. 2024 May 20:ljae208. doi: 10.1093.
PubMed

Contact allergies to dental material.
Br J Dermatol. 2024;190:e66.
PubMed

Predicting the likelihood of hidradenitis suppurativa disease progression based on identified risk factors.
Br J Dermatol. 2024;190:e67.
PubMed

The impact of atopic dermatitis on children and adolescents.
Br J Dermatol. 2024;190:e65.
PubMed

Incidence, mortality and survival in people with Merkel cell carcinoma: a systematic review.
Br J Dermatol. 2024;190:e64.
PubMed

PAVLENKO D, Akiyama T
Cryosim-1: a cool solution for acute and chronic itch.
Br J Dermatol. 2024;190:787.
PubMed

THANG CJ, Garate D, O'Leary S, Golovko G, et al
Evaluation of the association between tetracycline-class antibiotic use in patients with acne and idiopathic intracranial hypertension risk: a population-level cohort study.
Br J Dermatol. 2024;190:921-923.
PubMed

JAMES M, Nakamura M, Whittaker S, Morris S, et al
Mycosis fungoides: successful re-treatment with brentuximab vedotin.
Br J Dermatol. 2024;190:929-930.
PubMed

ZOUBOULIS CC, Passeron T, Pariser D, Wozniak MB, et al
Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials.
Br J Dermatol. 2024;190:836-845.
PubMed Abstract available

KIM DY
Mortality landscape of Behcet disease.
Br J Dermatol. 2024;190:784.
PubMed

BAHAR F, DeCaprio JA
Why do we distinguish between virus-positive and virus-negative Merkel cell carcinoma?
Br J Dermatol. 2024;190:785-786.
PubMed

LIAO V, Cornman HL, Ma E, Kwatra SG, et al
Prurigo nodularis: new insights into pathogenesis and novel therapeutics.
Br J Dermatol. 2024;190:798-810.
PubMed Abstract available

LEE S, Wei ET, Selescu T, Babes A, et al
Histamine- and pruritogen-induced itch is inhibited by a TRPM8 agonist: a randomized vehicle-controlled human trial.
Br J Dermatol. 2024;190:885-894.
PubMed Abstract available

GORDON ER, Trager MH, Kontos D, Weng C, et al
Ethical considerations for artificial intelligence in dermatology: a scoping review.
Br J Dermatol. 2024;190:789-797.
PubMed Abstract available

CHOI SR, Shin A, Ha YJ, Lee YJ, et al
All-cause and cause-specific mortality in patients with Behcet disease versus the general population.
Br J Dermatol. 2024;190:858-866.
PubMed Abstract available

JOHNSON O
Living with nodular prurigo.
Br J Dermatol. 2024;190:915.
PubMed

GREKOWITZ E, Metz M, Altrichter S, Bauer A, et al
Targeting histamine receptor 4 in cholinergic urticaria with izuforant (LEO 152020): results from a phase IIa randomized double-blind placebo-controlled multicentre crossover trial.
Br J Dermatol. 2024;190:825-835.
PubMed Abstract available

MARONESE CA, Marzano AV
Identifying candidates for early intervention in hidradenitis suppurativa.
Br J Dermatol. 2024;190:787-788.
PubMed

RAGAMIN A, Zhang J, Pasmans SGMA, Schappin R, et al
The construct validity, responsiveness, reliability and interpretability of the Recap of atopic eczema questionnaire (RECAP) in children.
Br J Dermatol. 2024;190:867-875.
PubMed Abstract available

TORRE-CASTRO J, Rodriguez M, Alonso-Alonso R, Mendoza Cembranos MD, et al
LT and SOX9 expression are associated with gene sets that distinguish Merkel cell polyomavirus (MCPyV)-positive and MCPyV-negative Merkel cell carcinoma.
Br J Dermatol. 2024;190:876-884.
PubMed Abstract available

KJAERSGAARD ANDERSEN R, Pedersen O, Eidsmo L, Jemec G, et al
Initial steps towards developing a predictive algorithm of disease progression for hidradenitis suppurativa (HS): results from a Cox proportional hazard regression analysis on disease progression among a cohort of 335 Danish patients with HS.
Br J Dermatol. 2024;190:904-914.
PubMed Abstract available

CHIESA FUXENCH ZC
The burden of atopic dermatitis across paediatric populations: 'it's not just an itch that rashes'.
Br J Dermatol. 2024;190:783-784.
PubMed

MISTRY K, Venables ZC
A systematic review of Merkel cell carcinoma epidemiology highlights its rising incidence, poor prognosis and data heterogeneity.
Br J Dermatol. 2024;190:782-783.
PubMed

MOHSEN ST, Price EL, Chan AW, Hanna TP, et al
Incidence, mortality and survival of Merkel cell carcinoma: a systematic review of population-based studies.
Br J Dermatol. 2024;190:811-824.
PubMed Abstract available

OLSEN CM
Ecological evidence for melanoma overdiagnosis in Denmark.
Br J Dermatol. 2024 May 16:ljae206. doi: 10.1093.
PubMed

DU J, Dong C, Lin J, Lu X, et al
MMP2hi Fibroblasts Regulate CD8+ T Cell Residency and Inflammation via CD100 in Psoriasis.
Br J Dermatol. 2024 May 16:ljae205. doi: 10.1093.
PubMed Abstract available

HAMMAS K, Nardin C, Boyer S, Michel C, et al
Incidence and trends of first basal cell carcinomas in France between 1980 and 2019: a regional population-based registry study.
Br J Dermatol. 2024 May 15:ljae201. doi: 10.1093.
PubMed Abstract available

TANAHASHI K, Kono M, Yoshikawa T, Suzuki Y, et al
Treating epidermolytic ichthyosis and ichthyosis with confetti with epidermal autografts cultured from revertant skin.
Br J Dermatol. 2024 May 13:ljae193. doi: 10.1093.
PubMed Abstract available

RODRIGUEZ M, Rebollo-Gonzalez M, Frutos Diaz-Alejo J, Manso R, et al
Mutational profiling of Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders do not resemble nodal peripheral T-cell lymphomas with follicular helper T-cell phenotype.
Br J Dermatol. 2024 May 13:ljae192. doi: 10.1093.
PubMed

PARRAGA SP, Feldman SR
Insulin resistance and psoriasis.
Br J Dermatol. 2024 May 13:ljae199. doi: 10.1093.
PubMed

BOITOR RA, Varma S, Sharma A, Odedra S, et al
Diagnostic accuracy of autofluorescence-Raman spectroscopy for surgical margin assessment during Mohs micrographic surgery of basal cell carcinoma.
Br J Dermatol. 2024 May 13:ljae196. doi: 10.1093.
PubMed Abstract available

PASSERON T, Reinhardt M, Ehst B, Weiss J, et al
Secukinumab in adult patients with lichen planus: Efficacy and safety results from the randomised, placebo-controlled, proof-of-concept PRELUDE study.
Br J Dermatol. 2024 May 13:ljae181. doi: 10.1093.
PubMed Abstract available

ROBINSON J, Kibbi N, Rajan N
Redefine "benign": A misnomer in the context of patients with genetic skin tumour syndromes.
Br J Dermatol. 2024 May 10:ljae185. doi: 10.1093.
PubMed

GUNTHER C
IL-17 blockade by secukinumab was not effective in controlling lichen planus in a randomized controlled clinical trial.
Br J Dermatol. 2024 May 8:ljae186. doi: 10.1093.
PubMed

ZHANG S, Ran M
Deceptive Pigment Changes in Neoadjuvant Sonidegib Therapy for Basal Cell Carcinoma.
Br J Dermatol. 2024 May 4:ljae187. doi: 10.1093.
PubMed

April 2024

MALLBRIS MJ, Jia B, Zhao Y, Kahlenberg JM, et al
Concomitant Moderate to Severe Cutaneous Lesions Have Marked Impact on Quality of Life in Patients with Active Systemic Lupus Erythematosus: A Cross-Sectional Insight from Two Phase 3 Randomised Clinical Trials in Adults.
Br J Dermatol. 2024 Apr 30:ljae183. doi: 10.1093.
PubMed

HALIOUA B, Skayem C, Merhand S, Ben Hayoun Y, et al
Long-term consequences on stigmatization and disease burden during adulthood among patients with childhood or adolescence-onset atopic dermatitis.
Br J Dermatol. 2024 Apr 29:ljae176. doi: 10.1093.
PubMed

O'REILLY M, Paolino A, Pathmarajah P, Ferguson J, et al
Dupilumab in Chronic Actinic Dermatitis: a retrospective case series.
Br J Dermatol. 2024 Apr 24:ljae180. doi: 10.1093.
PubMed

LI Y, He Y, Yang F, Liang R, et al
GSDME-mediated keratinocyte pyroptosis participates in the pathogenesis of psoriasis by promoting skin inflammation.
Br J Dermatol. 2024 Apr 24:ljae179. doi: 10.1093.
PubMed Abstract available

NIELSEN JB, Kristiansen IS, Thapa S
Increasing melanoma incidence with unchanged mortality: more sunshine, better treatment, increased diagnostic activity, overdiagnosis or lowered diagnostic threshold?
Br J Dermatol. 2024 Apr 24:ljae175. doi: 10.1093.
PubMed Abstract available

LEEOLOU MC, Sarin KY, Fiorentino DF
Filling the Prescription Gap: The Value of Community Support in Psoriasis Management.
Br J Dermatol. 2024 Apr 18:ljae168. doi: 10.1093.
PubMed

HUANG D, Zhong X, Jiang Y, Kong L, et al
Insulin Resistance Impairs Biological Agents Response in Moderate-to-Severe Plaque Psoriasis: Insights from a Prospective Cohort Study in China.
Br J Dermatol. 2024 Apr 18:ljae147. doi: 10.1093.
PubMed Abstract available

The association between vitamin D levels and psoriasis in people aged 40-79 years.
Br J Dermatol. 2024;190:e54.
PubMed

Effectiveness and safety of immunoadsorption in the treatment of pemphigus vulgaris and pemphigus foliaceus.
Br J Dermatol. 2024;190:e53.
PubMed

Predictors of response to treatment with biologics in people with moderate-to-severe psoriasis.
Br J Dermatol. 2024;190:e55.
PubMed

A novel strategy for the treatment of melanoma.
Br J Dermatol. 2024;190:e51.
PubMed

Practical guide for epidermolysis bullosa management in the first 4 weeks of life.
Br J Dermatol. 2024;190:e52.
PubMed

The Patient Benefit Index for topical treatment (PBI-TOP): a new questionnaire to assess the treatment goals and preferences of people with psoriasis.
Br J Dermatol. 2024;190:e56.
PubMed

Deciding on the final set of questions and groups of questions in the Patient-Reported Impact of Dermatological Diseases (PRIDD) tool.
Br J Dermatol. 2024;190:e57.
PubMed

Targeting malignant melanoma cells expressing the protein CD20 enhances BRAF-targeted treatment.
Br J Dermatol. 2024;190:e58.
PubMed

UK trends in work-related contact dermatitis caused by nickel, chromium and cobalt.
Br J Dermatol. 2024;190:e59.
PubMed

'Gene creams' for genetic diseases?
Br J Dermatol. 2024;190:e50.
PubMed

PASSERON T
A pledge for a better care and consideration of patients with vitiligo.
Br J Dermatol. 2024;190:614-615.
PubMed

SAMPOGNA F, Piaserico S
Deucravacitinib: is there still a place or a need for a new oral agent?
Br J Dermatol. 2024;190:610-611.
PubMed

HASAN SB, Bates J, Cannings-John R, Collier F, et al
Feasibility of daily pain measurement using text messages in hidradenitis suppurativa clinical trials; data from the THESEUS study.
Br J Dermatol. 2024;190:775-777.
PubMed

KYUNG S, Woo S, Kim M, Lee H, et al
Global burden of vaccine-associated alopecia, 1979-2023: a comprehensive analysis of the international pharmacovigilance database.
Br J Dermatol. 2024;190:764-767.
PubMed

MOSS C
Caring for babies born with epidermolysis bullosa.
Br J Dermatol. 2024;190:608.
PubMed

RING HC, Thorsen J, Kirby B, Ingram JR, et al
Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study.
Br J Dermatol. 2024;190:769-771.
PubMed

FAKIH A, Tannous R, Lajnef M, Seneschal J, et al
Stigma in vitiligo: associated factors and severity strata of the Patient Unique Stigmatization Holistic tool in Dermatology (PUSH-D) score.
Br J Dermatol. 2024;190:712-717.
PubMed Abstract available

HASHIMOTO T, Yamagami J
Development of a novel treatment for pemphigus and confirmation of its efficacy: a randomized controlled trial of protein A immunoadsorption therapy.
Br J Dermatol. 2024;190:609.
PubMed

RIVERA S, Dehner K, Flood A, Dykstra C, et al
Adverse healthcare experiences are correlated with increased time to diagnosis in women with vulvar inflammatory dermatoses: a retrospective cohort survey.
Br J Dermatol. 2024;190:761-762.
PubMed

VAN BEEK N, Eming R, Reuss A, Zillikens D, et al
Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomized controlled trial.
Br J Dermatol. 2024;190:657-667.
PubMed Abstract available

The 2024 British Skin Foundation Research Awards are now available.
Br J Dermatol. 2024;190:778.
PubMed

CHAIYABUTR C, Dawe R, Lesar A, Ibbotson SH, et al
A retrospective comparison of early- and late-onset chronic actinic dermatitis: characteristics and management.
Br J Dermatol. 2024 Apr 16:ljae101. doi: 10.1093.
PubMed

NASLUND-KOCH C, Skov L
Shedding light on the smoke: Unraveling the impact of smoking cessation on psoriasis development.
Br J Dermatol. 2024 Apr 15:ljae163. doi: 10.1093.
PubMed

PHILLIPS C, Russell E, McNiven A, McPherson T, et al
A Qualitative Study of the Psychological Morbidity in Paediatric Survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Br J Dermatol. 2024 Apr 12:ljae154. doi: 10.1093.
PubMed

BLANCHARD M, Morren MA, Busschots AM, Hauben E, et al
Paediatric onset lymphomatoid papulosis: results of a multicentre retrospective cohort study, on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG).
Br J Dermatol. 2024 Apr 10:ljae150. doi: 10.1093.
PubMed Abstract available

SIMPSON EL, Eckert L, Gadkari A, Brown TM, et al
Evaluating the clinical utility of the Atopic Dermatitis Control Tool: measurement properties and agreement between patients' responses and clinicians' impressions of atopic dermatitis control.
Br J Dermatol. 2024 Apr 9:ljae056. doi: 10.1093.
PubMed

JONES OT, Matin RN, Walter FM
Using artificial intelligence-based technologies to support the diagnosis and early detection of melanoma in primary care.
Br J Dermatol. 2024 Apr 9:ljae094. doi: 10.1093.
PubMed

CAO Q, Li M
GLMN variants cause skin hyperpigmentation: a promising potential therapeutic target.
Br J Dermatol. 2024 Apr 8:ljae149. doi: 10.1093.
PubMed

ROCCUZZO G, Calvao J, Dobos G, Morsia E, et al
Cutaneous T-cell lymphoma care across Europe: insights from the Horizon Project.
Br J Dermatol. 2024 Apr 5:ljae145. doi: 10.1093.
PubMed

March 2024

KIM SR, Choi YG, Jo SJ
Effect of smoking cessation on psoriasis vulgaris, palmoplantar pustulosis, and generalized pustular psoriasis.
Br J Dermatol. 2024 Mar 27:ljae130. doi: 10.1093.
PubMed Abstract available

SANDER N, Stolzl D, Fonfara M, Hartmann J, et al
Blockade of IL-13 signaling improves skin barrier function and biology in patients with moderate to severe atopic dermatitis.
Br J Dermatol. 2024 Mar 26:ljae138. doi: 10.1093.
PubMed Abstract available

BENTZ P, Weisshaar E
Biomarkers as key concepts in managing atopic dermatitis and psoriasis: Unlocking new ways of care for patient suffering from chronic hand dermatoses.
Br J Dermatol. 2024 Mar 26:ljae127. doi: 10.1093.
PubMed

JOHNSON C, Liao W
Food for thought: A comment on 'Breast-feeding decreases the risk of developing psoriasis through early adulthood'.
Br J Dermatol. 2024 Mar 26:ljae135. doi: 10.1093.
PubMed

SOROKIN AV, Gelfand JM
New Prospective Cohort Study and Mendelian Randomization Analysis Reveals a Link Between Psoriasis and Cardiovascular Risk Trough Elevated Plasma Triglycerides.
Br J Dermatol. 2024 Mar 22:ljae129. doi: 10.1093.
PubMed

TALTY R, Richmond R, Micevic G
Melanoma TIL therapy commences era of cell-based immunotherapies.
Br J Dermatol. 2024 Mar 22:ljae126. doi: 10.1093.
PubMed

Correction to: Circulating biomarkers are associated with disease severity of chronic hand eczema and atopic dermatitis.
Br J Dermatol. 2024 Mar 22:ljae112. doi: 10.1093.
PubMed

STRANDMOE AL, Bremer J, Diercks GFH, Gostynski A, et al
Beyond The Skin: B Cells in Pemphigus Vulgaris, Tolerance and Treatment.
Br J Dermatol. 2024 Mar 20:ljae107. doi: 10.1093.
PubMed Abstract available

JIANG X, Yang C, Wang Z, Liang L, et al
Loss-of-function variants in GLMN are associated with generalized skin hyperpigmentation with or without glomuvenous malformation.
Br J Dermatol. 2024 Mar 15:ljae108. doi: 10.1093.
PubMed Abstract available

AMBRA1 and loricrin as a test to identify low-risk early-stage melanoma.
Br J Dermatol. 2024;190:e46.
PubMed

Blood monitoring during psoriasis treatment with biologics.
Br J Dermatol. 2024;190:e47.
PubMed

Safety of bimekizumab over 3 years in patients with psoriasis.
Br J Dermatol. 2024;190:e38.
PubMed

International trends in the incidence of cutaneous squamous cell carcinoma and melanoma.
Br J Dermatol. 2024;190:e40.
PubMed

Skin barrier dysfunction drives skin inflammation via formylpeptide receptor 1.
Br J Dermatol. 2024;190:e45.
PubMed

2024 British Skin Foundation Small Grants are NOW AVAILABLE.
Br J Dermatol. 2024;190:603.
PubMed

Comparison of topical permethrin 5% and benzyl benzoate 25% for treating scabies.
Br J Dermatol. 2024;190:e39.
PubMed

Global consensus process to establish a core dataset for hidradenitis suppurativa registries.
Br J Dermatol. 2024;190:e42.
PubMed

The relationship between paediatric eczema and cognition.
Br J Dermatol. 2024;190:e41.
PubMed

A guide to using the core outcome set for eczema.
Br J Dermatol. 2024;190:e44.
PubMed

GARMAN KA, Thoreson N, Strong J, Hallaert P, et al
Mycophenolate mofetil inhibits Merkel cell carcinoma growth.
Br J Dermatol. 2024;190:593-595.
PubMed Abstract available

CORNMAN HL, Whang KA, Ma E, Aggarwal P, et al
Severity, impact on quality of life and mental health burden of pruritus in prurigo nodularis: a cross-sectional study of a diverse patient cohort.
Br J Dermatol. 2024;190:571-572.
PubMed

CLAIRE FULLER L, Sunderkotter C
Scabies therapy update: Should 25% benzyl benzoate emulsion be reconsidered as a first-line agent in classical scabies?
Br J Dermatol. 2024;190:459-460.
PubMed

NIELSEN W, Drucker AM
The need and benefit of the Harmonising Outcome Measures for Eczema user's guide.
Br J Dermatol. 2024;190:462-463.
PubMed

XIE W, Kong X, Zheng H, Mei H, et al
Rapid emergence of recalcitrant dermatophytosis caused by a cluster of multidrug-resistant Trichophyton indotineae in China.
Br J Dermatol. 2024;190:585-587.
PubMed

NANDA A, Chang YH, Cheng HC, Lai IT, et al
Autosomal recessive plantar keratoderma with ragged periungual hyperkeratosis caused by a homozygous missense variant in KRT16.
Br J Dermatol. 2024;190:588-590.
PubMed

COWPER R
For itch and insanity.
Br J Dermatol. 2024;190:568.
PubMed

BARLOW R, Ahmed A, Fellows J, Goulding J, et al
Assessing and managing the mental health of people with vitiligo: a UK-wide consultation exercise.
Br J Dermatol. 2024;190:574-576.
PubMed

MEYERSBURG D, Hoellwerth M, Brandlmaier M, Handisurya A, et al
Comparison of topical permethrin 5% vs. benzyl benzoate 25% treatment in scabies: a double-blinded randomized controlled trial.
Br J Dermatol. 2024;190:486-491.
PubMed Abstract available

MOSCARELLA E, Di Brizzi EV, Alpi P, Arcelli A, et al
Indications for adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma with clear margins: a Delphi consensus.
Br J Dermatol. 2024;190:578-579.
PubMed

DONHAUSER T, Gabes M, Ozkan E, Masur C, et al
What do Hyperhidrosis Quality of Life Index (HidroQoL(c)) scores mean? Transferring science into practice by establishing a score banding system.
Br J Dermatol. 2024;190:519-526.
PubMed Abstract available

WAINMAN HE, Chandran NS, Frew JW, Garg A, et al
Global consensus process to establish a core dataset for hidradenitis suppurativa registries.
Br J Dermatol. 2024;190:510-518.
PubMed Abstract available

GEORGE CD, Lee T, Hollestein LM, Asgari MM, et al
Global epidemiology of actinic keratosis in the general population: a systematic review and meta-analysis.
Br J Dermatol. 2024;190:465-476.
PubMed Abstract available

NALDI L, Cassalia F
Actinic keratosis epidemiology: the good, the bad and the ugly.
Br J Dermatol. 2024;190:457-458.
PubMed

OYESIKU L, Dlova N, Ahmed S, Owen DR, et al
Inclusive and equitable language for skin colour in the British Journal of Dermatology: acknowledging our past and laying the foundations to move forward.
Br J Dermatol. 2024 Mar 13:ljae064. doi: 10.1093.
PubMed

AALA WJF, Hou PC, Hong YK, Lin YC, et al
Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ Th2 cells which may contribute to pruritus in lesional skin.
Br J Dermatol. 2024 Mar 13:ljae110. doi: 10.1093.
PubMed Abstract available

Correction to: Malignancy risk in patients with atopic dermatitis: a population-based cohort study.
Br J Dermatol. 2024 Mar 12:ljae093. doi: 10.1093.
PubMed

CANTISANI C, Taliano A, Longo C, Bortone G, et al
Dynamic Optical Coherence Tomography and Reflectance Confocal Microscopy of Basal Cell Carcinoma of the Nipple-Areola Complex.
Br J Dermatol. 2024 Mar 12:ljae104. doi: 10.1093.
PubMed

ARMATO U, Dal Pra I
Discovering skin-rejuvenating matrikines - a basic and applied Dermatology new frontier.
Br J Dermatol. 2024 Mar 12:ljae100. doi: 10.1093.
PubMed

CHEN GF, Xu S, White MA, Cohen JM, et al
Association between atopic dermatitis and eating disorders: a cross-sectional study in the All of Us Research Program.
Br J Dermatol. 2024 Mar 11:ljae103. doi: 10.1093.
PubMed

RA AG, Littlewood Z, Barton A, Keevil B, et al
The use of serum methotrexate level as an assessment of biochemical drug adherence in psoriasis.
Br J Dermatol. 2024 Mar 8:ljae096. doi: 10.1093.
PubMed

REHBINDER EM, Warnberg Gerdin S, Hoyer A, Bradley M, et al
Frequent oil-baths and skin barrier during infancy in the PreventADALL study.
Br J Dermatol. 2024 Mar 6:ljae091. doi: 10.1093.
PubMed Abstract available

EL HACHEM M, De Marco R, Soria de Francisco JM, Audouze A, et al
Ichthyosis: multinational European study on patient characteristics and body sites involved with impact on quality of life.
Br J Dermatol. 2024 Mar 1:ljae082. doi: 10.1093.
PubMed

February 2024

RIBERO S, Quaglino P, Roccuzzo G
Unveiling cutaneous adverse events and prognosis in immunotherapy for melanoma and squamous cell carcinoma.
Br J Dermatol. 2024 Feb 29:ljae092. doi: 10.1093.
PubMed

RAMESSUR R, Dand N, Langan SM, Saklatvala J, et al
Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research- an inter-disciplinary perspective.
Br J Dermatol. 2024 Feb 29:ljae080. doi: 10.1093.
PubMed Abstract available

GREVE AM, Wulff AB, Bojesen SE, Nordestgaard BG, et al
Elevated plasma triglycerides increase risk of psoriasis: A cohort and Mendelian randomization study.
Br J Dermatol. 2024 Feb 27:ljae089. doi: 10.1093.
PubMed Abstract available

January 2024

SAAD R, Duipmans J, Yerlett N, Plevey K, et al
Neonatal Epidermolysis Bullosa: a clinical practice guideline.
Br J Dermatol. 2024 Jan 4:ljae006. doi: 10.1093.
PubMed Abstract available

December 2023

FORKEL S, Schubert S, Corvin L, Heine G, et al
Contact allergies to dental materials in patients.
Br J Dermatol. 2023 Dec 20:ljad525. doi: 10.1093.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.